Document:

Separation Agreement

 Exhibit 10.2 

SEPARATION AGREEMENT AND GENERAL RELEASE 

Health Insurance Innovations, Inc., a Delaware corporation (hereinafter “Employer” or “Company”), and Michael A. Petrizzo,
Jr., his heirs, executors, administrators, successors, and assigns (collectively referred to throughout this Agreement as “Employee”), agree to and intend to be legally bound by the following: 

1. Termination of Employment Agreement. 

a. Employee and Employer agree that the Employment Agreement, dated October 7, 2013, between Employer and Employee (the
“Employment Agreement”) is hereby terminated effective as of the date of this Separation Agreement and General Release (this “Agreement”), and neither the Employer nor the Employee shall have any further rights or obligations
thereunder other than as specifically set forth in this Agreement. 
 b. Notwithstanding the termination of the Employment
Agreement as provided above, Employee will continue to be employed by Employer on a full-time basis during the period from the date of this Agreement through and including August 31, 2015 (the “Transition Period”). During the
Transition Period, Employee will continue to have the duties and responsibilities set forth in Section 1 of the Employment Agreement plus such other duties and responsibilities that Employee was performing immediately prior to the date of this
Agreement. During the Transition Period, Employee will also assist and advise the Employer with the transition of his duties and responsibilities to other persons. Notwithstanding the foregoing, the Employer will have the right, during the
Transition Period, to reduce the scope of Employee’s responsibilities and duties and/or to transition Employee’s responsibilities and duties to other persons. The duties to be performed by Employee hereunder shall be principally performed
at Employee’s office in Villanova, Pennsylvania. Employee, however, will visit the Company’s offices in Tampa, Florida as reasonably requested by the Company. 

c. During the Transition Period, Employee will continue to be paid the compensation, be reimbursed for reasonable expenses, and
be entitled to those rights and benefits provided for under Sections 3(a), (d), and (f) of the Employment Agreement, but Employee will not be entitled to any other compensation set forth under the Employment Agreement other than as specifically
set forth in this Agreement. The Employer and Employee will have the right to terminate Employee’s employment during the Transition Period upon the same terms and subject to the same conditions as are set out in Section 4 of the Employment
Agreement, provided that upon any such termination, Employee will only be entitled to the compensation and/or benefits provided, as applicable, in this Agreement and in Sections 4(b)(i)(A) and (E), Section 4(b)(ii), Section 4(b)(iv) and
Section 4(b)(v)(A) of the Employment Agreement. 
 d. Employee hereby resigns, effective as of the close of business on
the last day of the Transition Period, from all officer and director positions held by him with the Employer and its subsidiaries and affiliates, including without limitation from the offices of Executive Vice President, General Counsel, and
Secretary of the Employer. However, 

 
upon written notice by Employer to Employee, Employer may at any time during the Transition Period remove Employee from any one or more of such offices or positions, including without limitation
in connection with the transition of Employee’s duties to other persons. 
 2. Consideration. In consideration for signing this
Separation Agreement and General Release (this “Agreement”) and in consideration of Employee’s adherence to the promises made herein, Employer agrees that: 

a. Commencing on September 1, 2015 or the earlier termination of the Transition Period for any reason, Employer will pay
Employee (or Employee’s legal representative) severance, in cash, the amount of $275,000, payable in equal installments for 12 months. All such payments to Employee shall be made in accordance with the Employer’s regular payroll schedule
and be subject to all legally required withholdings and taxes. However, no such payments shall be made to Employee any sooner than eight (8) days following his execution of the Employee Reaffirmation set forth on the last page of this Agreement
(which Employee Reaffirmation shall be executed and delivered to the Company no earlier than September 1, 2015 or, if applicable, the first day after the earlier termination of the Transition Period); provided, that delivery of an Employee
Reaffirmation shall not be required in the event of the Employee’s Death). 
 b. On or before the fifth (5th) business day after Employee delivers to Employer an executed Employee Reaffirmation, Employee shall be paid a cash bonus of $25,000 (minus applicable tax withholdings) so long as Employee has
successfully completed the Transition Period. Employee will be deemed to have successfully completed the Transition Period (a “Successful Transition Completion”) if any of the following apply: (i) Employee remains employed by the
Company pursuant to the Paragraph 1.b. hereof for the entirety of the Transition Period, (ii) Employee resigns his employment in a Resignation For Good Reason (as defined in the Employment Agreement) prior to the end of the Transition Period,
or (iii) Employer terminates Employee’s employment in a Termination Without Cause (as defined in the Employment Agreement) prior to the end of the Transition Period. For purposes of the preceding sentence, (A) the changes to
Employee’s employment contemplated or permitted by this Agreement shall not constitute a “Good Reason Event” under the Employment Agreement and (B) Employee’s pre-scheduled vacation to occur the last week of July 2015 shall
not constitute “Cause” under the Employment Agreement. 
 c. All benefits and accruals will cease as of
August 31, 2015 or the earlier termination of the Transition Period for any reason. Effective September 1, 2015 or the earlier termination of the Transition Period for any reason, Employee shall be eligible to continue his group medical
insurance benefits under the terms and conditions of the federal law commonly known as “COBRA.” Employer agrees to reimburse any COBRA continuation premiums paid by Employee for coverage through and including August 31, 2016 or the 12
month period following the earlier termination of the Transition Period for any reason (as applicable), such reimbursement to be made, minus applicable tax and other legally required withholdings, within fifteen (15) days after presentation by
Employee (or his legal representative) of an invoice for of such premiums. 

  
 2 

 d. Employer waives its rights to enforce the Covenant of Noncompetition contained
in Section 5(b) of the Employment Agreement from and after the Transition Period. Employee acknowledges and reaffirms his obligation to adhere at all times (subject, where applicable, to the Restricted Period (as defined in the Employment
Agreement)) to the other provisions of Section 5(b) of the Employment Agreement in accordance with their terms, including without limitation the covenants set forth in Sections 5(c), 5(d), 5(f), and 5(h) of the Employment Agreement. Employee
and Employer also both acknowledge and agree to as to their continuing obligations under Section 5(g) of the Employment Agreement. 

e. Employer agrees that: (i) all of Employee’s unvested Restricted Shares subject to the RSA Agreement (as those
terms are defined in the Employment Agreement) shall become fully vested and non-forfeitable, and all restrictions thereon shall lapse, as of the date of this Agreement, (ii) all Restricted Shares subject to the Restricted Stock Award
Agreement, dated April 8, 2015, between the Employer and Employee (the “April 2015 RSA Agreement”) shall become fully vested and non-forfeitable, and all restrictions thereon shall lapse as of the date of this Agreement,
(iii) unvested SARs subject to the SARA Agreement (as those terms are defined in the Employment Agreement) shall, as of the date of this Agreement, become fully vested and non-forfeitable to the extent set forth in the accelerated vesting
provisions of the SARA Agreement as though a Termination Without Cause (as defined in the Employment Agreement) occurred on the date hereof, and all restrictions thereon shall lapse as of such date, and all such SARs that become so vested shall
thereafter remain exercisable for the maximum period permitted under the SARA Agreement, and (iv) in exchange for the 25,000 SARs that will be forfeited on the last day of employment pursuant to the terms of the SARA Agreement, Employee will on
the date of this Agreement be granted an additional 25,000 SARs upon the terms set forth in a new SARA Agreement in the form attached hereto as Exhibit A (the “New SARA Agreement”). Employee agrees that Restricted Shares may be
withheld and/or transferred back to the Company in order to satisfy tax withholding obligations in accordance with the historical practices of the Company and the terms and conditions of the applicable award agreement. 

3. No Consideration Absent Execution of this Agreement. Employee understands and agrees that Employee would not receive the benefits
specified in Paragraphs 2 a. through e. above, except for Employee’s execution of this Agreement and the fulfillment of the promises contained herein. 

4. General Release of Claims. Employee for himself, his successors, assigns, attorneys, and all those entitled to assert his rights,
now and forever hereby releases and discharges the Company and its respective officers, directors, stockholders, trustees, Executives, agents, parent corporations, subsidiaries, affiliates, estates, successors, assigns and attorneys (the
“Released Parties”), from any and all claims, actions, causes of action, sums of money due, suits, debts, liens, covenants, contracts, obligations, costs, expenses, damages, judgments, agreements,

  
 3 

 
promises, demands, claims for attorney’s fees and costs, or liabilities whatsoever, in law or in equity, which the Executive ever had or now has against the Released Parties, arising by
reason of or in any way connected with or which may be traced either directly or indirectly to the employment relationship which existed between the Company or any of its parents, subsidiaries, affiliates, or predecessors and the Executive, or the
termination of that relationship, that the Executive has, had or purports to have, from the beginning of time to the date of this Agreement, whether known or unknown, that now exists, no matter how remotely they may be related to the aforesaid
employment relationship including but not limited to claims for employment discrimination under federal or state law, except as provided in Paragraph 2; claims arising under Title VII of the Civil Rights Act, 42 U.S.C. § 2000(e), et seq. or the
Americans With Disabilities Act, 42 U.S.C. § 12101, et seq.; claims for statutory or common law wrongful discharge, including any claims arising under the Fair Labor Standards Act, 29 U.S.C. § 201, et seq.; claims for attorney’s fees,
expenses and costs; claims for defamation; claims for wages or vacation pay; claims for benefits, including any claims arising under the Executive Retirement Income Security Act, 29 U.S.C. § 1001, et seq.; and provided, however, that nothing
herein shall release the Company of its obligations to the Executive under this Agreement, the surviving provisions of the Employment Agreement, the RSA Agreement (as defined in the Employment Agreement), the SARA Agreement (as defined in the
Employment Agreement), the Indemnification Agreement, dated as of October 21, 2013 (the “Indemnification Agreement”), between the Company and the Executive, the April 2015 RSA Agreement, penalties and taxes which may be assessed
against Employee by the Commonwealth of Pennsylvania for taxes and withholdings that were not made by the Company, or any other contractual obligations between the Company or its subsidiaries or affiliates and the Executive (including, without
limitation, any equity award agreement or indemnification agreement), or any indemnification obligations to the Executive under the Indemnification Agreement, the Company’s or any affiliates’ certificate of incorporation, bylaws, operating
agreement or other constituent document or any federal, state or local law or otherwise. 
 Release of Claims Under Age Discrimination in
Employment Act. Without limiting the generality of the foregoing, the Employee agrees that by executing this Agreement, he has released and waived any and all claims he has or may have as of the date of this Agreement for age discrimination
under the Age Discrimination in Employment Act, 29 U.S.C. § 621, et seq. It is understood that Employee has been advised to consult with an attorney prior to executing this Agreement; that he in fact has consulted a knowledgeable, competent
attorney regarding this Agreement; that he may, before executing this Agreement, consider this Agreement for a period of 21 calendar days; and that the consideration he receives for this Agreement is in addition to amounts to which he was already
entitled. It is further understood that this Agreement is not effective until seven calendar days after the execution of this Agreement and that the Executive may revoke this Agreement within seven calendar days from the date of execution hereof by
submitting written notice of his intent to revoke and delivering it to the Chief Financial Officer of the Company on or before the seventh day following execution. 

The release in this Paragraph 4 is intended to be a general release, and excludes only those claims under any statute or common law that
Employee is legally barred from releasing. 

  
 4 

 Nothing in this Agreement is intended to or shall prevent Employee from: a) filing a charge of
discrimination with the U.S. Equal Employment Opportunity Commission or any federal, state, or local government agency and/or cooperating with any such agency in any investigation or b) to challenge the knowing and voluntary nature of the waivers
and releases contained in this Agreement. Employee, however, explicitly waives any right to file a personal lawsuit, and similarly waives any right to receive monetary damages that the agency may recover against Releasees, without regard as to who
brought any said complaint or charge. 
 5. Affirmations. Employee represents and agrees by signing below that Employee has no known
workplace injuries or occupational diseases and that Employee has not filed, nor has Employee caused to be filed, nor is Employee presently a party to any claim, complaint, or action against Releasees in any forum or form. Employee further agrees
that he shall not divulge any information protected by the Attorney-Client Privilege. Other than the consideration set forth in Paragraphs 2 a. through e. of this Agreement, and any earned but unpaid or unreimbursed Salary, unreimbursed business
expenses or accrued benefits to which Employee is entitled to receive or entitled to be reimbursed for (as applicable) under the Employment Agreement as of the date of this Agreement, Employee affirms that Employee has been paid and/or has received
all leave (paid or unpaid), compensation, wages, bonuses and/or commissions to which Employee may be entitled and that no other leave (paid or unpaid), compensation, wages, bonuses and/or commissions are due to Employee. Furthermore, Employee
acknowledges that while employed with the Company and as of the date of this Agreement, Employee knows no fact, evidence, or information that would lead Employee to allege a violation of any rule, law or regulation against the Company, its
affiliates, related companies, or any employees other person or entity, or any of them, except for any matter which has already been reported to the Company. 

6. Survival of Provisions of Employment Agreement. Notwithstanding anything to the contrary set forth in this Agreement, Section 9
(Indemnification), Section 17 (Cooperation), and Section 18 (Non-disparagement) of the Employment Agreement shall survive the termination of the Employment Agreement and shall hereafter remain in full force and effect in accordance with
the terms of said Sections 9, 17 and 18. 
 7. Governing Law and Interpretation. This Agreement shall be governed by and construed in
accordance with the laws of the State of Florida without giving effect to the principles of conflicts of law. Employee hereby irrevocably submits to the personal and exclusive jurisdiction of the United States District Court for the Middle District
of Florida or the Courts of the State of Florida located within Hillsborough County, Florida in any action or proceeding arising out of, or relating to, this Agreement (whether such action arises under contract, tort, equity or otherwise). Employee
hereby irrevocably waives any objection which Employee now or hereafter may have to the laying of venue or personal jurisdiction of any such action or proceeding brought in said courts. Jurisdiction and venue of all such causes of action shall be
exclusively vested in the United States District Court for the Middle District of Florida or the Courts of the State of Florida located within Hillsborough County, Florida. Employee irrevocably waives Employee’s right to object to or challenge
the above selected forum on the basis of inconvenience or unfairness under 28 U.S.C. § 1404, or similar state or federal statutes. 

  
 5 

 8. Return of Employer Property. Employee agrees that as a condition for receiving any of
the benefits described in Paragraph 2 above, he will return, by the last day of the Transition Period, any and all of Employer’s property currently in Employee’s possession including any documents, reports, manuals, keys, credit cards,
security cards and passwords, and any other company documents or property whether stored electronically or otherwise. Employee agrees that he shall not keep copies of any company documents or information. 

9. Severability. If any term, provision or paragraph of this Agreement is determined by a court of competent jurisdiction to be invalid
or unenforceable for any reason, such determination shall be limited to the narrowest possible scope in order to preserve the enforceability of the remaining portions of the term, provision or paragraph, and such determination shall not affect the
remaining terms, provisions or paragraphs of this Agreement, which shall continue to be given full force and effect. 
 10. Non-admission
of Wrongdoing. The parties agree that neither this Agreement nor the furnishing of the consideration for this Agreement shall be deemed or construed at any time for any purpose as an admission by Employer or Employee, or evidence of any
liability or unlawful conduct of any kind. 
 11. Amendment. This Agreement may not be modified, altered or changed except in writing
and signed by both parties wherein specific reference is made to this Agreement. 
 12. Entire Agreement. Other than the other
agreements referred to herein, no prior or contemporaneous oral or written agreements or representations may be offered to alter the terms of this Agreement which, other than such other agreements referred to herein, represents the entire agreement
of the parties with respect to the subject matter hereof. 
 13. Signatures. This Agreement may be executed in counterparts, any such
copy of which to be deemed an original, but all of which together shall constitute the same instrument. 
 14. Assignment; Heirs.
Employer and Releasees have the right to assign this Agreement, but Employee does not. This Agreement inures to the benefit of the successors and assigns of the Employer, as well as the heirs of Employee, who are intended third party beneficiaries
of this Agreement. 
 [rest of page intentionally left blank] 

  
 6 

 EMPLOYEE IS ADVISED THAT EMPLOYEE HAS TWENTY ONE (21) CALENDAR DAYS TO CONSIDER THIS AGREEMENT. EMPLOYEE
IS HEREBY ADVISED TO CONSULT WITH AN ATTORNEY OF EMPLOYEE’S CHOICE PRIOR TO EXECUTION OF THIS AGREEMENT. 
 EMPLOYEE AGREES THAT ANY
MODIFICATIONS, MATERIAL OR OTHERWISE, MADE TO THIS AGREEMENT DO NOT RESTART OR AFFECT IN ANY MANNER THE ORIGINAL TWENTY-ONE (21) CALENDAR DAY CONSIDERATION PERIOD. 

EMPLOYEE FREELY AND KNOWINGLY ENTERS INTO THIS AGREEMENT INTENDING TO WAIVE, SETTLE AND RELEASE ALL RELEASABLE CLAIMS, INCLUDING CLAIMS OF AGE
DISCRIMINATION THAT EMPLOYEE HAS OR MIGHT HAVE AGAINST EMPLOYER. 
 IN WITNESS WHEREOF, the parties hereto knowingly and voluntarily executed this
Agreement as of the dates set forth below, with the date of this Agreement to be deemed the latest date executed by a party hereto: 
  

							
	HEALTH INSURANCE INNOVATIONS, INC.		EMPLOYEE
				
	By:		  /s/ Michael W. Kosloske
				  /s/ Michael A. Petrizzo, Jr.

			Michael W. Kosloske,				Michael A. Petrizzo, Jr., individually
			Chairman and Chief Executive Officer				
			
	Date: June 9, 2015				Date: June 9, 2015

  
 7 

 EMPLOYEE REAFFIRMATION 

In consideration for the payment of the amounts set forth in Paragraph 2 of the Separation Agreement and General Release, dated June 9, 2015, between
Michael A. Petrizzo, Jr. and Health Insurance Innovations, Inc. (the “Agreement”), minus all legally required withholding, I, Michael A. Petrizzo, Jr. do reaffirm and acknowledge that I remain bound by all of the terms of the Agreement,
including all of the releases and waivers contained therein, which releases and waivers shall also be deemed to be made as of the date hereof. 
  

	
	EMPLOYEE
	
	  

	Michael A. Petrizzo, Jr.

 Date:
                    , 2015 

 EXHIBIT A 

NEW SARA AGREEMENT 

 HEALTH INSURANCE INNOVATIONS, INC. 

LONG TERM INCENTIVE PLAN 

Stock Appreciation Rights Award Agreement 

You have been granted Stock Appreciation Rights (this “Award”) on the following terms and subject to the provisions of
Attachment A and the Long Term Incentive Plan (the “Plan”) of Health Insurance Innovations, Inc. (the “Company”). Unless defined in this Award (including Attachment A, this
“Agreement”), capitalized terms will have the meanings assigned to them in the Plan. In the event of a conflict among the provisions of the Plan, this Agreement and any descriptive materials provided to you, the provisions of the
Plan will prevail. 
  

					
	Participant				Michael A. Petrizzo, Jr.
			
	Number of Stock Appreciation Rights				25,000 (each a “SAR”)
			
	Exercise Price per SAR				$4.79
			
	Grant Date				June 9, 2015
			
	Expiration Date				June 9, 2022, subject to earlier termination under Section 2(d)(iii) of Attachment A.

 Vesting Schedule 

(subject to Section 2(c) and Section 2(d) of Attachment A) 

 

					
	Vesting				Subject to Section 2(c) and Section 2(d) of Attachment A, all of the SARs shall vest and become non-forfeitable on the date a Successful Transition Completion (as defined in the Separation Agreement and
General Release of even date herewith between the Company and Participant) has occurred.

 Attachment A 

Stock Appreciation Rights Award Agreement 

Terms and Conditions 

Grant to: Michael A. Petrizzo, Jr. 

Section 1. Grant of Stock Appreciation Rights. Subject to the terms and conditions of the Plan and this Agreement, the
Company hereby grants this Award to the Participant on the Grant Date on the terms set forth on the cover page of this Agreement, as more fully described in this Attachment A. This Award is granted under the Plan, which is incorporated
herein by this reference and made a part of this Agreement. 
 Section 2. Terms of SAR. 

(a) Generally. Subject to the terms and conditions of this Agreement and the Plan, each SAR constitutes an unfunded and unsecured
promise of the Company to deliver to Participant, at the time such SAR is validly exercised, an amount, payable in the form of Shares, equal to the excess of (i) the Fair Market Value of one Share on the date of exercise, over (ii) the
Exercise Price per SAR set forth on the cover page of this Agreement (the “Spread”). 
 (b) Exercisability. Subject
to the terms and conditions of this Agreement and the Plan, a SAR may be exercised only after if it has vested and become exercisable under Section 2(c) or Section 2(d)(ii), and only before it has expired or been terminated
under Section 2(d)(i) or Section 2(d)(iii). 
 (c) Vesting, Generally. 

(i) Subject to Section 2(d), the SARs shall vest and become exercisable in accordance with the Vesting Schedule set forth on the
cover page of this Agreement. 
 (ii) If the Participant holds unvested SARs at the time a Change in Control occurs, the SARs shall become
100% vested, non-forfeitable and exercisable, and all restrictions thereon shall lapse, on the date of the Change in Control immediately prior to the consummation thereof. 

 (d) Termination. 

(i) Except as otherwise provided in this Section 2(d), all of the SARs shall terminate at 5:00 p.m., Eastern time, on the
Expiration Date set forth on the cover page of this Agreement, unless earlier terminated under subsection (ii) below. 
 (ii)
In the event that a Successful Transition Completion has not occurred on or before September 1, 2015, the SARs granted under this Agreement shall automatically and immediately terminate on September 1, 2015 and be forfeited back to the
Company. 
 For clarity, in no event shall any SAR be exercisable after the Expiration Date set forth on the cover page of this Agreement. 

(e) Transferability. The SARs, and the Participant’s rights under this Agreement, shall not be assigned, sold, transferred or
otherwise be subject to alienation by the Participant, other than by will or the law of descent and distribution, and any purported assignment, sale, transfer or other alienation not permitted hereunder shall be void. During the Participant’s
lifetime, the SARs shall be exercisable only by the Participant. 
 Section 3. Exercise. 

(a) When to Exercise. Except as otherwise provided in the Plan or this Agreement, the Participant (or in the case of exercise after the
Participant’s death or incapacity, the Participant’s guardian, legal representative, heir or legatee, as the case may be) may exercise his or her SARs that are then exercisable under Section 2, in whole or in part, by following
the procedures set forth in this Section 3. If partially exercised, the Participant (or in the case of exercise after the Participant’s death or incapacity, the Participant’s guardian, legal representative, heir or legatee, as
the case may be) may thereafter exercise the remaining unexercised portion of the SARs, to the extent that they are then exercisable under Section 2, by following the procedures set forth in this Section 3. 

(b) Election to Exercise. To exercise the SARs, the Participant (or in the case of exercise after the Participant’s death or
incapacity, the Participant’s guardian, legal representative, heir or legatee, as the case may be) must deliver to the Secretary of the Company 

 
(or his or her designee) a written notice (or notice through another previously approved method, which could include a web-based or e-mail system) which sets forth the number of SARs being
exercised, together with any additional documents as the Company may require. Each such notice must satisfy whatever then-current procedures apply to the SARs and must contain such representations, warranties and covenants as the Company requires.
If someone other than the Participant exercises the SARs, then such person must submit documentation reasonably acceptable to the Company verifying that such person has the legal right to exercise the SARs. 

(c) Date of Exercise. The SARs shall be deemed to be exercised on the business day that the Company receives a fully executed and
completed exercise notice. If an exercise notice is received on a day that is not a business day, or is received after 5:00 p.m., Eastern time, on a business day, then the SARs shall be deemed to be exercised on the first business day
immediately following the day such notice is received by the Company. 
 (d) Settlement. Upon a valid exercise of SARs, the
Participant shall be entitled to receive that number of Shares determined by dividing (i) (1) the total number of SARs then being exercised, multiplied by (2) the Spread on the date of exercise, by (ii) the Fair Market Value of
one Share on the date of exercise. 
 (e) Fractional Shares. No fractional Shares shall be issued upon exercise of SARs, and if the
number of Shares otherwise issuable under Section 3(d) upon an exercise of SARs includes a fraction of a Share, then upon such exercise the Participant shall be entitled to receive (i) the number of Shares determined under
Section 3(d), rounded down to the nearest whole Share, plus (ii) an amount of cash equal to the Fair Market Value of one Share on the date of exercise, multiplied by such fraction of a Share. 

(f) Withholding Requirements. The delivery of Shares upon settlement of SARs is conditioned on the Participant making arrangements
satisfactory to the Company to enable the Company to satisfy all tax (or other governmental obligation) withholding requirements. In the event that there is any such withholding requirement upon an exercise of SARs, the Committee may, in its sole
discretion and pursuant to such procedures as the Committee may require, permit the Participant to satisfy any such withholding requirement by having the Company withhold from the number of Shares otherwise issuable to the Participant upon such
exercise a number of 

 
Shares having an aggregate Fair Market Value equal to the minimum amount required to be withheld. If the Committee permits the Participant to satisfy any such withholding requirement pursuant to
the preceding sentence, the Company shall remit to the Internal Revenue Service and appropriate state and local revenue agencies, for the credit of the Participant, an amount of cash withholding equal to the Fair Market Value of the Shares withheld
by the Company as provided above. 
 (g) Compliance with Law and Regulations. The SARs, their exercise and the obligation of the
Company to issue Shares in settlement thereof are subject to all applicable federal and state laws, rules and regulations, including securities laws, to approvals by any government or regulatory agency as may be required, and to the rules,
regulations and other requirements of the stock market or exchange upon which the Shares are then quoted, traded or listed. The Participant may not exercise a SAR if such exercise would violate any securities laws or other applicable law, rule,
regulation or requirement. 
 Section 4. No Rights of Stockholder. A holder of a SAR, as such, shall not be entitled to
vote or receive dividends or be deemed the holder of the Shares underlying the SAR for any purpose, nor shall anything contained in this Agreement be construed to confer upon the holder of a SAR, as such, any of the rights or obligations of a
stockholder of the Company, unless and until Shares are actually issued to and held of record by such holder upon settlement of the SARs following valid exercise thereof. 

Section 5. Change in Control. Without limiting the Committee’s power under the Plan, upon the occurrence of a Change
in Control, the Committee is authorized (but not obligated) to make adjustments to the terms and conditions of the SARs without the need for the consent of the Participant, including, without limitation, the following (or any combination
thereof): 
 (a) The Committee may provide for the continuation or assumption of the SARs and this Agreement by the acquiring or
successor entity (or parent thereof), including the Company if it is the surviving entity, or for the substitution of the SARs and this Agreement with a substitute award with terms comparable to the SARs and this Agreement (in each case with
appropriate adjustments as to the Exercise Price and the number and type of Shares (or other securities) underlying the Award or substitute award). The determination of such appropriate adjustments and comparability shall be made by the Committee.

 (b) The Committee may provide for the cancellation of all or any portion of the SARs for their
Intrinsic Value (payable in the form of cash, stock, securities, other property or any combination thereof) based upon the price per Share received or to be received by other stockholders of the Company in the Change in Control transaction. If at
the time of a Change in Control such Intrinsic Value is equal to or less than zero (i.e., the Exercise Price of the SARs equals or exceeds the price per Share received or to be received by other stockholders of the Company in the Change in Control
transaction), then the Committee may provide for the cancellation of the SARs without the payment of any consideration therefor. 

Section 6. Miscellaneous Provisions. 

(a) Notices. All notices, requests and other communications under this Agreement (other than a notice of exercise, which shall be
provided in accordance with Section 3) shall be in writing and shall be delivered in person (by courier or otherwise), mailed by certified or registered mail, return receipt requested, or sent by facsimile transmission, as follows: 

if to the Company, to: 
 Health
Insurance Innovations, Inc. 
 15438 N. Florida Avenue, Suite 201 

Tampa, Florida, 33613 

Attention: Chief Executive Officer 

Telecopy: (877) 376-5832 

with a copy to (which shall not constitute notice hereunder): 

Health Insurance Innovations, Inc. 

15438 N. Florida Avenue, Suite 201 

Tampa, Florida, 33613 

Attention: Chief Financial Officer 

Telecopy: (877) 376-5832 

 if to the Participant, to the address that the Participant most recently provided to the Company,

 or to such other address or facsimile number as such party may hereafter specify for the purpose by notice to the other parties hereto. All such notices,
requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. on a business day in the place of receipt. Otherwise, any such notice, request or communication shall be
deemed received on the next succeeding business day in the place of receipt. 
 (b) Entire Agreement. This Agreement, the Plan and
any other agreements referred to herein and therein and any attachments referred to herein or therein, constitute the entire agreement and understanding between the parties in respect of the subject matter hereof and supersede all prior and
contemporaneous arrangements, agreements and understandings, both oral and written, whether in term sheets, presentations or otherwise, between the parties with respect to the subject matter hereof. 

(c) Amendment; Waiver. No amendment or modification of any provision of this Agreement shall be effective unless signed in
writing by or on behalf of the Company and the Participant, except that the Committee may amend or modify this Agreement without the Participant’s consent in accordance with the provisions of the Plan or as otherwise set forth in this
Agreement. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition whether of like or different nature. Any amendment or modification of or to any provision of this
Agreement, or any waiver of any provision of this Agreement, shall be effective only in the specific instance and for the specific purpose for which made or given. 

(d) Successors and Assigns; No Third Party Beneficiaries. This Agreement shall inure to the benefit of and be binding upon the Company
and the Participant and their respective heirs, successors, legal representatives and permitted assigns. Nothing in this Agreement, expressed or implied, is intended to confer on anyone other than the Company and the Participant, and their
respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement. 

 (e) Counterparts. This Agreement may be signed in any number of counterparts, each of
which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 
 (f) Plan.
The Participant acknowledges and understands that material definitions and provisions concerning this Award and the Participant’s rights and obligations with respect thereto are set forth in the Plan. The Participant has read carefully, and
understands, the provisions of the Plan. 
 (g) Governing Law. The Agreement shall be governed by the laws of the State of Florida,
without application of the conflicts of law principles thereof. 
 (h) No Right to Continued Service. The granting of the Award
evidenced hereby and this Agreement shall impose no obligation on the Company or any Affiliate to continue the service of the Participant and shall not lessen or affect the right that the Company or any Affiliate may have to terminate the service of
such Participant. 
 (i) WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN
ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 
 IN WITNESS WHEREOF, the parties
have executed this Agreement as of the day and year first written above. 
  

			
	HEALTH INSURANCE INNOVATIONS, INC.
		
	By:		  

			Michael W. Kosloske
			Chairman and Chief Executive Officer
	
	PARTICIPANT
	
	  

	Michael A. Petrizzo, Jr.EX-4.2

 Exhibit 4.2 

 
  

STARBUCKS CORPORATION 

$850,000,000 

$500,000,000 2.700% SENIOR NOTES DUE 2022 

$350,000,000 4.300% SENIOR NOTES DUE 2045 
  

 
 FOURTH
SUPPLEMENTAL INDENTURE 
 Dated as of June 10, 2015 

To 
 INDENTURE 

Dated as of August 23, 2007 
  

 
 DEUTSCHE BANK
TRUST COMPANY AMERICAS 
 Trustee 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	ARTICLE 1.	  
	DEFINITIONS AND INCORPORATION BY REFERENCE	  
			
	Section 1.01	 	 Relationship with Base Indenture
	  	 	1	  
	Section 1.02	 	 Definitions
	  	 	2	  
	Section 1.03	 	 Other Definitions
	  	 	8	  
	
	ARTICLE 2.	  
	THE NOTES	  
			
	Section 2.01	 	 Form and Dating
	  	 	8	  
	Section 2.02	 	 Transfer and Exchange
	  	 	9	  
	Section 2.03	 	 Issuance of Additional Notes
	  	 	14	  
	
	ARTICLE 3.	  
	REDEMPTION AND PREPAYMENT	  
			
	Section 3.01	 	 Notice of Redemption
	  	 	14	  
	Section 3.02	 	 Notes Redeemed in Part
	  	 	14	  
	Section 3.03	 	 Optional Redemption
	  	 	14	  
	Section 3.04	 	 Mandatory Redemption
	  	 	15	  
	
	ARTICLE 4.	  
	PARTICULAR COVENANTS	  
			
	Section 4.01	 	 Liens
	  	 	15	  
	Section 4.02	 	 Offer to Purchase Upon Change of Control Triggering Event
	  	 	17	  
	Section 4.03	 	 Sale and Lease-Back Transactions
	  	 	19	  
	
	ARTICLE 5.	  
	SUCCESSORS	  
			
	Section 5.01	 	 Merger, Consolidation or Sale of Assets
	  	 	20	  
	
	ARTICLE 6.	  
	DEFAULTS AND REMEDIES	  
			
	Section 6.01	 	 Events of Default
	  	 	21	  
	
	ARTICLE 7.	  
	MISCELLANEOUS	  
			
	Section 7.01	 	 Trust Indenture Act Controls
	  	 	22	  
	Section 7.02	 	 Governing Law
	  	 	22	  
	Section 7.03	 	 Successors
	  	 	22	  
	Section 7.04	 	 Severability
	  	 	22	  
	Section 7.05	 	 Counterpart Originals
	  	 	22	  
	Section 7.06	 	 Table of Contents, Headings, Etc
	  	 	22	  

  
 i 

 TABLE OF CONTENTS 

(continued) 
  

			
	EXHIBITS	  	 
		
	Exhibit A	  	FORM OF 2022 NOTE
		
	Exhibit B	  	FORM OF 2045 NOTE

  
 ii 

 FOURTH SUPPLEMENTAL INDENTURE dated as of June 10, 2015, by and between Starbucks
Corporation, a Washington corporation (the “Company”), and Deutsche Bank Trust Company Americas, a New York banking corporation, as trustee (the “Trustee”). 

The Company has heretofore executed and delivered to the Trustee an indenture, dated as of August 23, 2007 (the “Base
Indenture”, and together with this Fourth Supplemental Indenture, the “Indenture”), providing for the issuance from time to time of one or more series of the Company’s securities. 

The Company desires and has requested the Trustee pursuant to Section 9.01 of the Base Indenture to join with it in the execution and
delivery of this Fourth Supplemental Indenture in order to supplement the Base Indenture as, and to the extent set forth herein to provide for the issuance and the terms of the Notes (as defined below). 

Section 9.01 of the Base Indenture provides that the Company and the Trustee, without the consent of any holders of the Company’s
Securities, may amend or waive certain terms and conditions in the Base Indenture as permitted by Sections 2.01 and 2.02 thereof. 
 The
execution and delivery of this Fourth Supplemental Indenture has been duly authorized by a resolution of the Board of Directors of the Company or a duly authorized committee thereof. 

All conditions and requirements necessary to make this Fourth Supplemental Indenture a valid, binding and legal instrument in accordance with
its terms have been performed and fulfilled by the parties hereto and the execution and delivery thereof have been in all respects duly authorized by the parties hereto. 

The Company and the Trustee agree as follows for the benefit of each other and for the equal and ratable benefit of the Holders (as
defined herein) of the 2.700% Senior Notes due 2022 (the “2022 Notes”) and 4.300% Senior Notes due 2045 (the “2045 Notes” and, together with the 2022 Notes, the “Notes”): 

ARTICLE 1. 
 DEFINITIONS AND
INCORPORATION BY REFERENCE 
 Section 1.01 Relationship with Base Indenture. 

The terms and provisions contained in the Base Indenture will constitute, and are hereby expressly made a part of this Fourth Supplemental
Indenture and the Company and the Trustee, by their execution and delivery of this Fourth Supplemental Indenture, expressly agree to such terms and provisions and to be bound thereby. However, to the extent any-provision of the Base Indenture conflicts with the express provisions of this Fourth Supplemental Indenture, the provisions of this Fourth Supplemental Indenture will govern and be controlling. 

The Trustee accepts the amendment of the Base Indenture effected by this Fourth Supplemental Indenture and agrees to execute the trust created
by the Base Indenture as hereby amended, but only upon the terms and conditions set forth in this Fourth Supplemental Indenture, including the terms and provisions defining and limiting the liabilities and responsibilities of the

 
Trustee in the performance of the trust created by the Base Indenture, and without limiting the generality of the foregoing, the Trustee will not be responsible in any manner whatsoever for or
with respect to any of the recitals or statements contained herein, all of which recitals or statements are made solely by the Company, or for or with respect to (1) the validity or sufficiency of this Fourth Supplemental Indenture or any of
the terms or provisions hereof, (2) the proper authorization hereof by the Company, (3) the due execution hereof by the Company or (4) the consequences (direct or-indirect- and whether deliberate or inadvertent) of any amendment herein provided for, and the Trustee makes no representation with respect to any such matters. 

Section 1.02 Definitions. Capitalized terms used herein without definition shall have the respective meanings set forth in
the Base Indenture. The following terms have the meanings given to them in this Section 1.02: 
 “Additional
Notes” means any Notes (other than the Initial Notes) issued under this Fourth Supplemental Indenture in accordance with Sections 2.03 hereof, as part of the same series as either series of the Initial Notes. 

“Applicable Procedures” means, with respect to any transfer or exchange of or for beneficial interests in any Global
Note, the rules and procedures of the Depositary that apply to such transfer or exchange. 
 “Attributable
Debt” with regard to a Sale and Lease-Back Transaction with respect to any Principal Property means, at the time of determination, the lesser of (A) the present value of the total net amount of lease payments required to be paid under
such lease during the remaining term thereof (after deducting the amount of rent to be received under non-cancellable subleases and including any period for which such lease has been extended), discounted at the greater of (x) the weighted
average interest rate per annum borne by the Notes or (y) the interest rate inherent in such lease, in each case, as determined by the Chief Financial Officer, Treasurer or Controller of the Company, compounded semiannually, or (B) the
sale price for the Principal Property so sold and leased multiplied by a fraction the numerator of which is the remaining portion of the base term of the lease included in such Sale and Lease-Back Transaction and the denominator of which is the base
term of such lease. In the case of any lease which is terminable by the lessee upon the payment of a penalty, such net amount shall be the lesser of (i) the net amount determined assuming termination upon the first date such lease may be
terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may be so terminated) or
(ii) the net amount determined assuming no such termination. 
 For purposes of determining such Attributable Debt,
“lease payments” are the aggregate amount of the rent payable by the lessee with respect to the applicable period, after excluding amounts required to be paid on account-of
maintenance and repairs, water rates and similar utility charges. If and to the extent the amount of any lease payment during any future period is not definitely determinable under the lease in question, the amount of such, lease-payment will be estimated in such reasonable manner as the Chief Financial Officer, Treasurer or Controller of the Company may in good faith
determine. 

  
 2 

 “Base Indenture” has the meaning set forth in the preamble to this Fourth
Supplemental Indenture, as amended, supplemented or otherwise modified from time to time in accordance with the terms thereof. 

“Below Investment Grade Rating Event” means with respect to either series of the Notes, the Notes are rated below an
Investment Grade Rating by each of the Rating Agencies on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the 60-day period following public notice of the occurrence of the
Change of Control (which 60-day period shall be extended so long as the rating of such Notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies); provided that a Below Investment Grade Rating Event
otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of
Change of Control Triggering Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the Trustee in writing at its request that the reduction
was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the
Below Investment Grade Rating Event). 
 “Capital Stock” means: 

(1) with respect to any Person that is a corporation, any and all shares, interests, participations or other equivalents
(however designated and whether or not voting) of corporate stock, including each class of Common Stock and Preferred Stock of such Person; and 

(2) with respect to any Person that is not a corporation, any and all partnership, membership or other equity interests of
such Person. 
 “Change of Control” means the occurrence of one or more of the following events: 

(1) any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or
substantially all of the assets of the Company to any Person or group of related Persons for purposes of Section 13(d) of the Exchange Act (a “Group”), together with any Affiliates thereof (whether or not otherwise in
compliance with the provisions of the Indenture); 
 (2) the approval by the holders of Capital Stock of the Company of any
plan or proposal for the liquidation or dissolution of the Company (whether or not otherwise in compliance with the provisions of the Indenture); 

(3) any Person or Group shall become the owner, directly or indirectly, beneficially or of record, of shares representing more
than 50% of the aggregate ordinary voting power represented by the issued and outstanding Capital Stock of the Company; or 

(4) during any period of 24 consecutive months, a majority of the members of the Board of Directors or other equivalent
governing body of the Company cease to be 

  
 3 

 
composed of individuals (i) who were members of such Board of Directors or equivalent governing body on the first day of such period, (ii) whose election or nomination to such Board of
Directors or equivalent governing body was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of such Board of Directors or equivalent governing body or
(iii) whose election or nomination to such Board of Directors or other equivalent governing body was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a
majority of such Board of Directors or equivalent governing body (excluding, in the case of both clause (ii) and clause (iii), any individual whose initial nomination for, or assumption of office as, a member of such Board of Directors or
equivalent governing body occurs as a result of an actual or threatened solicitation of proxies or consents for the election or removal of one or more directors by any person or group other than a solicitation for the election of one or more
directors by or on behalf of the Board of Directors). 
 Notwithstanding the foregoing, a transaction will not be deemed to involve a Change
of Control if (i) the Company becomes a wholly owned Subsidiary of a holding company and (ii) the holders of the Voting Stock of such holding company immediately following such transaction are substantially the same as the holders of the
Company’s Voting Stock immediately prior to such transaction. 
 “Change of Control Triggering Event” means the
occurrence of both a Change of Control and a Below Investment Grade Rating Event. 
 “Common Stock” of any
Person means any and all shares, interests or other participations in, and other equivalents (however designated and whether voting or non-voting) of, such Person’s common stock, and includes, without limitation, all series and classes of such
Common Stock. 
 “Comparable Treasury Issue” means, with respect to each Reference Treasury Dealer, the
United States Treasury security selected by such Reference Treasury Dealer as having a maturity comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of those Notes. 

“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of the Reference Treasury
Dealer Quotations for the redemption date, after excluding the highest and lowest Reference Treasury Dealer Quotations, or (ii) if the Trustee obtains fewer than four Reference Treasury Dealer Quotations, the average of all Reference Treasury
Dealer Quotations. 
 “Consolidated Net Tangible Assets” means, as of any date on which the Company effects a
transaction requiring such Consolidated Net Tangible Assets to be measured hereunder, the aggregate amount of assets (less applicable reserves) after deducting therefrom: (a) all current liabilities, except for current maturities of long-term
debt and obligations under capital leases; and (b) intangible assets, to the extent included in said aggregate amount of assets, all as set forth in the Company’s most recent consolidated balance sheet and computed in accordance with GAAP
applied on a consistent basis. 

  
 4 

 “Credit Agreement” means the Credit Agreement, dated as of
February 5, 2013, among the Company, as borrower, Bank of America, N.A., as administrative agent, swing line lender and L/C issuer, Wells Fargo Bank, N.A. and Citibank, N.A., as co-syndication Agents, Goldman Sachs Bank USA, JPMorgan Chase
Bank, N.A., The Bank of Nova Scotia, U.S. Bank National Association and Morgan Stanley MUFG Loan Partners, LLC, as co-documentation agents, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Wells Fargo Securities, LLC, and Citigroup
Global Markets Inc. as joint lead arrangers and joint book managers, and each of the other Lenders a party thereto, including any related letters of credit, notes, guarantees, collateral documents, instruments and agreements executed in connection
therewith, in each case, as amended, restated, modified, renewed, refunded, replaced or refinanced from time to time by one or more credit facilities, in which case, the credit agreement or similar agreement together with all other documents and
instruments related thereto shall constitute the “Credit Agreement” under the Indenture, whether with the same or different agents and lenders. 

“Definitive Note” means a certificated Note registered in the name of the Holder thereof and issued in accordance with
Section 2.02 hereof, substantially in the form of either Exhibit A or Exhibit B hereto except that such Note will not bear the Global Note Legend. 

“Depositary” means, with respect to the Notes, DTC and any successor thereto designated as depositary for the Notes
pursuant to Section 2.02 of this Fourth Supplemental Indenture. 
 “Fourth Supplemental Indenture” means
this Fourth Supplemental Indenture, dated as of the date hereof, by and among the Company and the Trustee, governing the Notes, as amended, supplemented or otherwise modified from time to time in accordance with the Base Indenture and the terms
hereof. 
 “Funded Debt” means Indebtedness, whether or not contingent, for money borrowed (including all
obligations evidenced by bonds, debentures, notes or similar instruments) owed or guaranteed by the Company or any consolidated Subsidiary, and any of the debt which under GAAP would appear as debt on the consolidated balance sheet of the
Company. 
 “Global Note Legend” means the legend set forth in Section 2.02(f), which is required to be
placed on all Global Notes issued under this Fourth Supplemental Indenture. 
 “Global Notes” means,
individually and collectively, each of the Global Notes, in the forms of Exhibit A and Exhibit B hereto issued in accordance with Section 2.01 hereof. 

“Holder” means a Person in whose name a Note is registered. 

“Indenture” means the Base Indenture, as supplemented by this Fourth Supplemental Indenture, governing the Notes, in
each case, as amended, supplemented or restated from time to time. 

  
 5 

 “Indirect Participant” means a Person who holds a beneficial interest in
a Global Note through a Participant. 
 “Initial Notes” means each of the first $500,000,000 aggregate
principal amount of 2022 Notes and $350,000,000 aggregate principal amount of 2045 Notes issued under this Fourth Supplemental Indenture on the date hereof. 

“Investment Grade Rating” means a rating equal to or higher than Baa3 (or the equivalent) by Moody’s and BBB- (or
the equivalent) by S&P, or, in each case, if such Rating Agency ceases to rate either series of the Notes or fails to make a rating of such series of Notes publicly available for reasons outside of the Company’s control, the equivalent
investment grade credit rating by the replacement agency selected by the Company in accordance with the procedures described below. 

“Material Subsidiary” means each Subsidiary of the Company that meets either of the following tests: (a) its
assets equal or exceed three percent of total assets of the Company and its Subsidiaries on a consolidated basis, or (b) its revenues equal or exceed three percent of the total revenues of the Company and its Subsidiaries on a consolidated
basis; provided that (i) if the Subsidiaries that meet either of the tests in (a) or (b), when combined with revenues generated or assets owned directly by the Company (excluding any assets located or revenues generated at the Subsidiary
level), aggregate less than 90% of the total assets or total revenues of the Company and its Subsidiaries on a consolidated basis, the Company shall designate additional Subsidiaries to constitute Material Subsidiaries until such threshold is met,
and (ii) once a Subsidiary is deemed a Material Subsidiary, whether by virtue of the tests in (a) or (b) above, or a result of designation pursuant to part (i) of this proviso, such Subsidiary shall continue to constitute a
Material Subsidiary throughout the term of either series of the Notes. 
 “Moody’s” means Moody’s
Investors Service, Inc., a subsidiary of Moody’s Corporation, and its successors. 
 “Nonrecourse
Obligation” means Indebtedness or lease payment obligations related to (i) the acquisition of a Principal Property not previously owned by the Company or any Subsidiary or (ii) the financing of a project involving the development
or expansion of any Principal Property owned by the Company or any Subsidiary, as to which the obligee with respect to such Indebtedness or obligation has no recourse to the Company or any Subsidiary or any of the Company’s or its
Subsidiaries’ assets other than such Principal Property so acquired, developed or expanded, as applicable. 

“Notes” has the meaning assigned to it in the preamble to this Fourth Supplemental Indenture. The Initial Notes of
each series and the Additional Notes of such series will be treated as a single class for all purposes under this Fourth Supplemental Indenture, and unless the context otherwise requires, all references to the Notes will include the Initial Notes
and any Additional Notes. 
 “Participant” means, with respect to the Depositary, a Person who has an account
with the Depositary. 

  
 6 

 “Person” has the meaning set forth in the Indenture and includes a
“person” as used in Section 13(d)(3) of the Exchange Act. 
 “Preferred Stock” of any Person
means any Capital Stock of such Person that has preferential rights to any other Capital Stock of such Person with respect to dividends or redemptions or upon liquidation. 

“Principal Property” means any individual facility or real property, or portion thereof, owned or hereafter acquired
by the Company or any Subsidiary and located within the United States of America, which, in the good faith opinion of the Company’s Chief Executive Officer, President, or Chief Financial Officer, is of material importance to the total business
conducted by the Company and its Subsidiaries taken as a whole, provided that no such individual facility or property will be deemed of material importance if its gross book value (excluding therefrom any equipment and before deducting
accumulated depreciation) is less than 1.0% of the Consolidated Net Tangible Assets of the Company. With respect to any Sale and Lease-Back Transaction or series of related Sale and Lease-Back Transactions, the determination of whether any property
is a Principal Property shall be determined by reference to all properties affected by such transaction or series of transactions. As of the date hereof, the only Principal Properties of the Company consist of the Carson Valley Roasting Plant
located at 2525 Starbucks Way, Minden, Nevada, the York Roasting Plant, located at 3000 Espresso Way, York, Pennsylvania and the Sandy Run Roasting Plant located at 114 Sirens Lane, Gaston, South Carolina. 

“Rating Agencies” means (1) each of Moody’s and S&P; and (2) if any of Moody’s or S&P
ceases to rate the Notes or fails to make a rating of the Notes publicly available for reasons outside of the Company’s control, a “nationally recognized statistical rating organization,” as defined in Section 3(a)(62) of the
Exchange Act, selected by the Company (as certified by a resolution of its Board of Directors) as a replacement agency for Moody’s or S&P, or both of them, as the case may be. 

“Reference Treasury Dealer” means (i) Citigroup Global Markets Inc., Merrill Lynch, Pierce, Fenner &
Smith Incorporated, and Morgan Stanley & Co. LLC (or their respective affiliates which are Primary Treasury Dealers (as defined below)) and their respective successors; provided, however, that if any of the foregoing shall cease to be a
primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), the Company will substitute another Primary Treasury Dealer; and (ii) any other Primary Treasury Dealer selected by the Company.

 “Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any
redemption date, the average, as determined by a Reference Treasury Dealer, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Company and the
Trustee by that Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding that redemption date. 

“S&P” means Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc., and
its successors. 

  
 7 

 “Sale and Lease-Back Transaction” means any arrangement with any Person
providing for the leasing by the Company or any Subsidiary of any Principal Property, whether now owned or hereafter acquired, which Principal Property has been or is to be sold or transferred by the Company or such Subsidiary to such Person and
which lease is required by GAAP to be capitalized on the balance sheet of such lessee. 
 “Subsidiary” means
any corporation, limited liability company or other similar type of entity in which the Company and/or one or more of its subsidiaries together own voting stock, membership interests or other capital securities having the power to elect a majority
of the Board of Directors or similar governing body of such corporation, limited liability company or other similar type of entity, directly or indirectly. For the purposes of this definition, “voting stock” means stock or other
capital securities which ordinarily have voting power for the election of directors or similar governing body, whether at all times or only so long as no senior class of stock or other capital securities have such voting power by reason of any
contingency. 
 “Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the
semiannual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date.

 Section 1.03 Other Definitions. 
  

						
	 Term
	  	Defined
in Section
	 “Change of Control Date”
	  	 	 	4.02	 
	 “Change of Control Offer”
	  	 	 	4.02	 
	 “Change of Control Payment Date”
	  	 	 	4.02	 
	 “Change of Control Purchase Price”
	  	 	 	4.02	 
	 “DTC”
	  	 	 	2.02	 
	 “Event of Default”
	  	 	 	6.01	 
	 “Mortgage”
	  	 	 	4.01	 

 ARTICLE 2. 

THE NOTES 

Section 2.01 Form and Dating. 

(a) General. The Notes and the Trustee’s certificate of authentication will be substantially in the forms of
Exhibit A and Exhibit B hereto. The Notes may have notations, legends or endorsements required by law, stock exchange rule or usage. Each Note will be dated the date of its authentication. The Notes will be in denominations
of $2,000 with integral multiples of $1,000 thereof. 
 The terms and provisions contained in the Notes will constitute, and are
hereby expressly made, a part of this Fourth Supplemental Indenture and the Company and the Trustee, by their execution and delivery of this Fourth Supplemental Indenture, expressly agree to such terms and provisions and to be bound thereby.
However, to the extent any provision of any Note conflicts 

  
 8 

 
with the express provisions of the Base Indenture, the provisions of the Note will govern and be controlling, and to the extent any provision of the Note conflicts with the express provisions of
this Fourth Supplemental Indenture, the provisions of this Fourth Supplemental Indenture will govern and be controlling. 
 (b)
Global Notes. Notes issued in global form will be substantially in the forms of Exhibit A and Exhibit B attached hereto (including the Global Note Legend thereon). Notes issued in definitive form will be substantially in
the forms of Exhibit A and Exhibit B attached hereto (but without the Global Note Legend thereon). Each Global Note will represent such of the outstanding Notes as will be specified therein and each will provide that it will
represent the aggregate principal amount of outstanding Notes from time to time endorsed thereon and that the aggregate principal amount of outstanding Notes represented thereby may from time to time be reduced or increased, as appropriate, to
reflect exchanges and redemptions. Any endorsement of a Global Note to reflect the amount of any increase or decrease in the aggregate principal amount of outstanding Notes represented thereby will be made by the Trustee or the Custodian, at the
direction of the Trustee, in accordance with instructions given by the Holder thereof as required by Section 2.02 hereof. 

Section 2.02 Transfer and Exchange. 

(a) Transfer and Exchange of Global Notes. A Global Note may not be transferred as a whole except by the Depositary to a nominee
of the Depositary, by a nominee of the Depositary to the Depositary or to another nominee of the Depositary, or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary. All Global Notes of a series
will be exchanged by the Company for Definitive Notes if: 
 (1) the Company delivers to the Trustee notice from the
Depositary that (A) it is unwilling or unable to continue to act as Depositary and a successor Depositary is not appointed by the Company within 90 days after the date of such notice from the Depositary or (B) it is no longer a
clearing agency registered under the Exchange Act; or 
 (2) the Company in its sole discretion determines that the Global
Notes of such series (in whole but not in part) should be exchanged for Definitive Notes and delivers a written notice to such effect to the Trustee. 

Upon the occurrence of either of the preceding events in (1) or (2) above, Definitive Notes will be issued in such names and in any
approved denominations as the Depositary will instruct the Trustee. Global Notes also may be exchanged or replaced, in whole or in part, as provided in Sections 2.08 and 2.11 of the Base Indenture. Every Note authenticated and delivered in exchange
for, or in lieu of, a Global Note or any portion thereof, pursuant to this Section 2.02 or Section 2.08 or 2.11 of the Base Indenture, will be authenticated and delivered in the form of, and will be, a Global Note. A Global Note may not be
exchanged for another Note other than as provided in this Section 2.02(a); however, beneficial interests in a Global Note may be transferred and exchanged as provided in Sections 2.02(b), (c) or (g) hereof. 

(b) Transfer and Exchange of Beneficial Interests in the Global Notes. The transfer and exchange of beneficial interests in the
Global Notes will be effected through the Depositary,  

  
 9 

 
in accordance with the provisions of this Fourth Supplemental Indenture and the Applicable Procedures. Transfers of beneficial interests in the Global Notes also will require compliance with
either subparagraph (1) or (2) below, as applicable, as well as one or more of the other following subparagraphs, as applicable: 

(1) Transfer of Beneficial Interests in the Same Global Note. Beneficial interests in any Global Note may be
transferred to Persons who take delivery thereof in the form of a beneficial interest in a Global Note. No written orders or instructions will be required to be delivered to the Registrar to effect the transfers described in this
Section 2.02(b)(1). 
 (2) All Other Transfers and Exchanges of Beneficial Interests in Global Notes. In
connection with all transfers and exchanges of beneficial interests that are not subject to Section 2.02(b)(1).above, the transferor of such beneficial interest must deliver to the Registrar
either: 
 (A) (i) a written order from a Participant or an Indirect Participant given to the Depositary in accordance with
the Applicable Procedures directing the Depositary to credit or cause to be credited a beneficial interest in another Global Note in an amount equal to the beneficial interest to be transferred or exchanged; and 

(ii) instructions given in accordance with the Applicable Procedures containing information regarding the Participant account
to be credited with such increase. 
 Upon satisfaction of all of the requirements for transfer or exchange of beneficial interests in
Global Notes contained in this Fourth Supplemental Indenture and the Notes or otherwise applicable under the Securities Act, the Trustee will adjust the principal amount of the relevant Global Note(s) pursuant to Section 2.02(g) hereof. 

(c) Transfer or Exchange of Beneficial Interests for Definitive Notes. 

If any holder of a beneficial interest in a Global Note proposes to exchange such beneficial interest for a Definitive Note or to transfer
such beneficial interest to a Person who takes delivery thereof in the form of a Definitive Note, then, upon satisfaction of the conditions set forth in Section 2.02(b)(2) hereof, the Trustee will cause the aggregate principal amount of the
applicable Global Note to be reduced accordingly pursuant to Section 2.02(g) hereof, and the Company will execute and, upon receipt of an Authentication Order, the Trustee will authenticate and deliver to the Person designated in the
instructions a Definitive Note in the appropriate principal amount. Any Definitive Note issued in exchange for a beneficial interest pursuant to this Section 2.02(c) will be registered in such name or names and in such authorized denomination
or denominations as the holder of such beneficial interest requests through instructions to the Registrar from or through the Depositary and the Participant or Indirect Participant. The Trustee will deliver such Definitive Notes to the Persons in
whose names such Notes are so registered. 
 (d) Transfer and Exchange of Definitive Notes for Beneficial Interests. 

  
 10 

 A Holder of a Definitive Note may exchange such Note for a beneficial interest in a Global
Note or transfer such Definitive Notes to a Person who takes delivery thereof in the form of a beneficial interest in a Global Note at any time. Upon receipt of a request for such an exchange or transfer, the Trustee will cancel the
applicable Definitive Note and increase or cause to be increased the aggregate principal amount of one of the Global Notes. 
 If any
such exchange or transfer from a Definitive Note to a beneficial interest is effected pursuant to the previous paragraph at a time when a Global Note has not yet been issued, the Company will issue and, upon receipt of an Authentication Order, the
Trustee will authenticate one or more Global Notes in an aggregate principal amount equal to the principal amount of Definitive Notes so transferred. 

A Holder of Definitive Notes may transfer such Notes to a Person who takes delivery thereof in the form of a Definitive Note. 

(e) Transfer and Exchange of Definitive Notes for Definitive Notes. Upon request by a Holder of Definitive Notes and such
Holder’s compliance with the provisions of this Section 2.02(e), the Registrar will register the transfer or exchange of Definitive Notes. Prior to such registration of transfer or exchange, the requesting Holder will present or
surrender to the Registrar the Definitive Notes duly endorsed or accompanied by a-written instruction of transfer in form satisfactory to the Registrar duly executed by such Holder or by his
attorney, duly authorized in writing. In addition, the requesting Holder will provide any additional certifications, documents and information, as applicable, required pursuant to the following provisions of this Section 2.02(e).

 (f) Legends. The following legends will appear on the face of all Global Notes issued under this Fourth Supplemental
Indenture unless specifically stated otherwise in the applicable provisions of this Fourth Supplemental Indenture. 
 “THIS
GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE FOURTH SUPPLEMENTAL INDENTURE GOVERNING THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES
EXCEPT THAT (I) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO SECTION 2.02 OF THE FOURTH SUPPLEMENTAL INDENTURE, (II) THIS GLOBAL NOTE MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.02(a) OF THE
FOURTH SUPPLEMENTAL INDENTURE, (III) THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.12 OF THE BASE INDENTURE AND (IV) THIS GLOBAL NOTE MAY BE TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN
CONSENT OF THE COMPANY. 
 UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY NOT BE
TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER 

  
 11 

 
NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER STREET, NEW YORK, NEW YORK) (“DTC”) TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF
CEDE & CO. OR SUCH OTHER NAME AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE
OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.” 

(g) Cancellation and/or Adjustment of Global Notes. At such time as all beneficial interests in a particular Global Note have
been exchanged for Definitive Notes or a particular Global Note has been redeemed, repurchased or canceled in whole and not in part, each such Global Note will be returned to or retained and canceled by the Trustee in accordance with
Section 2.12 of the Base Indenture. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in
another Global Note or for Definitive Notes, the principal amount of Notes represented by such Global Note will be reduced accordingly and an endorsement will be made on such Global Note by the Trustee or by the Depositary at the direction of the
Trustee to reflect such reduction; and if the beneficial interest is being exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Note, such other Global Note will be increased
accordingly and an endorsement will be made on such Global Note by the Trustee or by the Depositary at the direction of the Trustee to reflect such increase. 

(h) General Provisions Relating to Transfers and Exchanges. 

(1) To permit registrations of transfers and exchanges, the Company will execute and, upon receipt of an Authentication Order,
the Trustee will authenticate Global Notes and Definitive Notes upon the Company’s order or at the Registrar’s request. 

(2) No service charge will be made to a holder of a beneficial interest in a Global Note or to a Holder of a Definitive Note
for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than any such transfer taxes or similar
governmental charge payable upon exchange or transfer pursuant to Section 4.02 hereof and Sections 2.11, 3.06 and 9.05 of the Base Indenture). 

(3) The Registrar will not be required to register the transfer of or exchange any Note selected for redemption in whole or in
part, except the unredeemed portion of any Note being redeemed in part. 

  
 12 

 (4) All Global Notes and Definitive Notes issued upon any registration of transfer or exchange of
Global Notes or Definitive Notes will be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Fourth Supplemental Indenture, as the Global Notes or Definitive Notes surrendered upon such
registration of transfer or exchange. 
 (5) The Company will not be required: 

(A) to issue, to register the transfer of or to exchange any Notes during a period of 15 days before the day of any
selection of Notes for redemption under Section 3.02 of the Base Indenture and ending at the close of business on the day of selection; 

(B) to register the transfer of or to exchange any Note so selected for redemption in whole or in part, except the unredeemed
portion of any Note being redeemed in part; or 
 (C) to register the transfer of or to exchange a Note between a record
date and the next succeeding interest payment date. 
 (6) Prior to due presentment for the registration of a transfer of any Note, the
Trustee, any Agent and the Company may deem and treat the Person in whose name any Note is registered as the absolute owner of such Note for the purpose of receiving payment of principal of and interest on such Notes and for all other purposes, and
none of the Trustee, any Agent or the Company will be affected by notice to the contrary. 
 (7) The Trustee will authenticate Global Notes
and Definitive Notes in accordance with the provisions of Section 2.03 of the Base Indenture. 
 (8) All certifications, certificates
and Opinions of Counsel required to be submitted to the Registrar pursuant to this Section 2.02 to effect a registration of transfer or exchange may be submitted by facsimile. 

(9) The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed
under this Fourth Supplemental Indenture or under applicable law with respect to any transfer of any interest in any Note other than to require delivery of such certificates and other documentation or evidence as are expressly required by, and to do
so if and when expressly required by the terms of, this Fourth Supplemental Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof. 

(10) Neither the Trustee nor any Agent shall have any responsibility for any actions taken or not taken by the Depositary. 

  
 13 

 Section 2.03 Issuance of Additional Notes. 

The Company will be entitled, upon delivery of an Officer’s Certificate and an Opinion of Counsel, to issue Additional Notes of a series
under this Fourth Supplemental Indenture which will have identical terms as the Initial Notes of such series issued on the date hereof, other than with respect to the date of issuance, and in some cases, issue price and the first interest payment
date. The Initial Notes of each series issued on the date hereof and any Additional Notes of such series issued will be treated as a single class for all purposes under this Fourth Supplemental Indenture. 

With respect to any Additional Notes, the Company will set forth in a resolution of its Board of Directors and an Officer’s Certificate,
a copy of each which will be delivered to the Trustee, the following information: 
 (a) the aggregate principal amount of such Additional
Notes to be authenticated and delivered pursuant to this Fourth Supplemental Indenture; and 
 (b) the issue price, the issue date and the
CUSIP number of such Additional Notes. 
 ARTICLE 3. 

REDEMPTION AND PREPAYMENT 

Section 3.01 Notice of Redemption. 

The Company will deliver to the Trustee, at least 45 days prior to the redemption date (or such shorter period as the Trustee in its sole
discretion may allow), an Officer’s Certificate requesting that the Trustee give such notice and setting forth the information to be stated in such notice as provided in Section 3.03 of the Base Indenture. 

Section 3.02 Notes Redeemed in Part. 

No Notes of $2,000 or less can be redeemed in part. 

Section 3.03 Optional Redemption. 

In the case of the 2022 Notes, at any time prior to April 15, 2022 (two months prior to the maturity date of the 2022 Notes), and, in the
case of the 2045 Notes, at any time prior to December 15, 2044 (six months prior to the maturity date of the 2045 Notes), the Notes will be redeemable, in whole at any time or in part from time to time, at the Company’s option, at a
redemption price equal to the greater of: 
 (i) 100% of the aggregate principal amount of the Notes to be redeemed; or 

(ii) the sum of the present values of the remaining scheduled payments of principal and interest on the Notes being redeemed
(not including any portion of any payments of interest accrued to the redemption date) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 12 basis points, in
the case of the 2022 Notes, and 20 basis points, in the case of the 2045 Notes, 

  
 14 

 plus, in each case, accrued and unpaid interest on the Notes being redeemed to the redemption
date. 
 Calculation of the foregoing shall be made by the Company or on the Company’s behalf by such Person as the Company
shall designate; provided, however, that such calculation shall not be a duty or obligation of the Trustee. 
 In the
case of the 2022 Notes, at any time on and after April 15, 2022 (two months prior to the maturity date of the 2022 Notes), and in the case of the 2045 Notes, at any time on and after December 15, 2044 (six months prior to the maturity date
of the 2045 Notes), the Notes will be redeemable in whole at any time or in part from time to time, at the Company’s option, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed plus accrued and unpaid
interest on the principal amount being redeemed to the date of redemption. 
 On and after the redemption date, interest will cease to
accrue on the Notes or portions thereof called for redemption as long as the Company has deposited with the Paying Agent funds in satisfaction of the applicable redemption price. 

Section 3.04 Mandatory Redemption. 

Except as set forth in Section 4.02, the Company is not required to make any mandatory redemption or sinking fund payments with respect
to the Notes. 
 ARTICLE 4. 

PARTICULAR COVENANTS 

Section 4.01 Liens. 

(a) The Company will not, and will not permit any of its Subsidiaries to, issue, incur, create, assume or guarantee any Funded Debt
secured by a mortgage, deed of trust, security interest, pledge, lien, charge or other encumbrance (collectively, a “Mortgage”) upon any Principal Property or upon any shares of stock or Indebtedness of any Subsidiary that owns any
Principal Property (whether such Principal Property, shares or Indebtedness are now existing or owed or hereafter created or acquired) without in any such case effectively providing, concurrently with the issuance, incurrence, creation, assumption
or guaranty of any such Funded Debt, or the grant of such Mortgage, that the Notes (together with, if the Company shall so determine, any other Indebtedness of or guaranty by the Company or such Subsidiary ranking equally with the Notes) shall be
secured equally and-ratably with (or, at the Company’s option, prior to) such Funded Debt; provided that any Mortgage created for the benefit of the Holders of the Notes pursuant to this
provision shall provide by its terms that such Mortgage shall be automatically and unconditionally released and discharged upon the release and discharge of the Mortgage that resulted in such provision becoming applicable. The foregoing restriction,
however, will not apply to each of the following and therefore the following Mortgages (and the Funded Debt secured thereby), will be excluded from any computation under subsection (b) of this Section 4.01 and Section 4.03(b):

 (1) Mortgages on property, shares of stock or Indebtedness or other assets of any Person existing at the time such
Person becomes a Subsidiary; 

  
 15 

 (2) Mortgages on property, shares of stock or Indebtedness or other assets
existing at the time of acquisition thereof by the Company or a Subsidiary, or Mortgages thereon to secure the payment of all or any part of the purchase price thereof or the cost of construction, installation, renovation, improvement or development
thereon or thereof, or Mortgages on property, shares of stock or Indebtedness or other assets to secure any Indebtedness incurred or guaranteed prior to, at the time of, or within 360 days after, the latest of the acquisition thereof or, in the
case of property, the completion of such construction, installation, renovation, improvement or development or the commencement of substantial commercial operation of such property for the purpose of financing all or any part of the purchase price
thereof, such construction, installation, renovation, improvement or development; 
 (3) Mortgages in favor of the Company
or a Subsidiary to secure Funded Debt owing to the Company or to a Subsidiary; 
 (4) Mortgages existing on the date hereof;

 (5) Mortgages on property, shares of stock or Indebtedness or assets of a Person existing at the time such Person is
merged into or consolidated with the Company or a Subsidiary or at the time of a sale, lease or other disposition of properties of such Person as an entirety or substantially as an entirety to the Company or a Subsidiary; 

(6) Mortgages in favor of the United States of America or any state, territory or possession thereof (or the District of
Columbia), or any foreign government, or any department, agency, instrumentality or political subdivision of the United States of America or any state, territory or possession thereof (or the District of Columbia) or any foreign government, to
secure partial, progress, advance or other payments pursuant to any contract or statute or to secure any Indebtedness incurred or guaranteed for the purpose of financing all or any part of the purchase price or the cost of constructing or improving
the property subject to such Mortgages (including, but not limited to, Mortgages incurred in connection with pollution control or industrial revenue bonds or similar financing); 

(7) Mortgages created in connection with a project financed with, and created to secure, a Nonrecourse Obligation; or 

(8) extensions, renewals, refundings, or replacements, in whole or in part, of any Mortgage referred to in the foregoing
clauses; provided, however, that (A) the principal amount of Funded Debt secured thereby shall not exceed the principal amount of Funded Debt, plus any premium or fee payable in connection with any such extension, renewal,
refunding or replacement, so secured at the time of such extension, renewal, refunding or replacement and (B) such extension, renewal, refunding, or replacement Mortgages will be limited to all or part of the same property, shares of stock or
Indebtedness or assets and improvement or development thereon or thereof which secured the Indebtedness so secured at the time of such extension, renewal, refunding or replacement. 

  
 16 

 (b) Notwithstanding the restrictions set forth in the first sentence of the preceding paragraph,
the Company or any Subsidiary may issue, incur, create, assume or guarantee Funded Debt secured by a Mortgage which would otherwise be subject to such restrictions, without equally and ratably securing the .Notes, provided that after giving effect thereto, the aggregate amount of all Funded Debt so secured by Mortgages (not including Funded Debt secured by Mortgages permitted under clauses
(1) through (8) of the second sentence of paragraph (a) above) plus the aggregate amount of all Attributable Debt in respect of Sale and Lease-Back Transactions relating to Principal Properties (excluding any Attributable Debt
permitted to be incurred pursuant to clauses (1) through (8) of paragraph (a) of Section 4.03 hereof) does not exceed 15 percent of the Company’s Consolidated Net Tangible Assets. 

Section 4.02 Offer to Purchase Upon Change of Control Triggering Event. 

(a) Upon the occurrence of a Change of Control Triggering Event (the date of such occurrence, the “Change of Control Date”),
unless the Company has exercised its right to redeem the Notes pursuant to Section 3.03, each Holder shall have the right to require the Company to .purchase such Holder’s Notes in
whole or in part at a purchase price (the “Change of Control Purchase Price”) equal to 101% of the principal amount of such Notes, plus accrued and unpaid interest, if any, to the date of purchase (the “Change of Control
Payment Date”), pursuant to and in accordance with the offer described in this Section 4.02 (the “Change of Control Offer”). 

(b) Within 30 days following the Change of Control Date, or at the Company’s option, prior to any Change of Control but after public
announcement of the pending Change of Control, the Company shall send, by first class mail, a notice to each Holder, with a copy to the Trustee, which notice shall govern the terms of the Change of Control Offer. Such notice shall state: 

(i) that the Change of Control Offer is being made pursuant to this Section 4.02 and that all Notes validly tendered will
be accepted for payment; 
 (ii) the Change of Control Purchase Price and the Change of Control Payment Date, which shall be
a Business Day that is no earlier than 30 days nor later than 60 days from the date such notice is mailed, other than as may be required by law; 

(iii) that any Note not tendered will continue to accrue interest; 

(iv) that any Note accepted for payment pursuant to the Change of Control Offer shall cease to accrue interest after the
Change of Control Payment Date unless the Company shall default in the payment of the Change of Control Purchase Price of the Notes and the only remaining right of the Holder is to receive payment of the Change of Control Purchase Price upon
surrender of the Notes to the Paying Agent; 

  
 17 

 (v) that Holders electing to have a portion of a Note purchased pursuant to a
Change of Control Offer may only elect to have such Note purchased in integral multiples of $1,000; 
 (vi) that if a Holder
elects to have a Note purchased pursuant to the Change of Control Offer it will be required to surrender the Note, with the form entitled “Option of Holder to Elect Purchase” on the reverse of the Note completed, or transfer by
book-entry transfer, to the Paying Agent at the address specified in the-notice prior to the close of business on the third Business Day prior to the Change of Control Payment Date; 

(vii) that a Holder will be entitled to withdraw its election if the Company receives, not later than the third Business Day
preceding the Change of Control Payment Date, a telegram, telex, facsimile transmission or letter setting forth the name of such Holder, the principal amount of Notes such Holder delivered for purchase, and a statement that such Holder is
withdrawing its election to have such Note purchased; and 
 (viii) that if Notes are purchased only in part a new Note of
the same type will be issued in a principal amount equal to the unpurchased portion of the Notes surrendered. 
 (c) On or before the Change
of Control Payment Date, the Company shall, to the extent lawful, accept for payment, all Notes or portions thereof validly tendered pursuant to the Change of Control Offer, and shall deliver to the Trustee an Officer’s Certificate stating that
such Notes or portions thereof were accepted for payment by the Company in accordance with the terms of this Section 4.02. The Company, the Depositary or the Paying Agent, as the case may be, shall promptly mail or deliver to each tendering
Holder an amount equal to the purchase price of the Notes tendered by such Holder and accepted by the Company for purchase, and the Company shall promptly issue a new Note, and the Trustee, upon receipt of an Authentication Order, shall authenticate
and mail or deliver such new Note to such Holder, in a principal amount equal to any unpurchased portion of the Note surrendered. Any Note not so accepted shall be promptly mailed or delivered by the Company to the Holder thereof. 

(d) The Company shall comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations
thereunder to the extent such laws and regulations are applicable in connection with the repurchase of Notes pursuant to an offer hereunder. To the extent the provisions of any securities laws or regulations conflict with the provisions under this
Section 4.02, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this Section 4.02 by virtue thereof. 

(e) The Company shall not be required to make a Change of Control Offer if a third party makes such an offer in the manner, at the times and
otherwise in compliance with the requirements for such an offer made by the Company and such third party purchases all Notes properly tendered and not withdrawn under its offer. 

  
 18 

 Section 4.03 Sale and Lease-Back Transactions. 

(a) The Company will not, and will not permit any of its Subsidiaries to, enter into any Sale and Lease-Back Transaction with respect to any
Principal Property. The foregoing restriction, however, will not apply to, and therefore there will be excluded from any computation under subsection (b) below and under subsection (b) of Section 4.01, any Sale and Lease-Back
Transaction (and any Attributable Debt relating thereto) if: 
 (1) the Company or a Subsidiary is permitted to create
Funded Debt secured by a Mortgage pursuant to any of clauses (1) through (8) inclusive under the second sentence of subsection (a) of Section 4.01 on the Principal Property involved in such Sale and Lease-Back Transaction, in an
amount at least equal to the Attributable Debt with respect to such Sale and Lease-Back Transaction, without equally and ratably securing the Notes; 

(2) the proceeds of such Sale and Lease-Back Transaction are at least equal to the fair market value of the affected Principal
Property (as determined in good faith by the Company’s Chief Executive Officer, President, Chief Financial Officer, Treasurer or Controller) and the Company or a Subsidiary applies an amount equal to the net proceeds of such Sale and Lease-Back
Transaction within 360 days thereof to the prepayment or retirement of debt for borrowed money of the Company or a Subsidiary (other than debt that is subordinated to the Notes or debt owed to the Company or a Subsidiary); 

(3) the Company or a Subsidiary apply an amount equal to the net proceeds of such Sale and Lease-Back Transaction within 360
days thereof to the purchase, construction, development, expansion or improvement of other property; 
 (4) such Sale and
Lease-Back Transaction involves a lease for a term, including renewals, of not more than three years; 
 (5) such Sale and
Lease-Back Transaction is between the Company and a Subsidiary, or between Subsidiaries; 
 (6) such Sale and Lease-Back
Transaction is executed at the time of, or within 12 months after the latest of the acquisition, the completion of construction or improvement, or the commencement of substantial commercial operation, of the Principal Property covered thereby; 

(7) the lease in such Sale and Lease-Back Transaction secures or relates to industrial revenue or pollution control bonds if
the Company is permitted to incur a Mortgage in connection with such industrial revenue or pollution control bonds pursuant to clause (6) of the second sentence of subsection (a) of Section 4.01; or 

(8) the lease payment in such Sale and Lease-Back Transaction is created in connection with a project financed with, and such
obligation constitutes, a Nonrecourse Obligation. 

  
 19 

 (b) Notwithstanding the restrictions in the first sentence of subsection (a), the Company or any
Subsidiary may enter into any Sale and Lease-Back Transaction with respect to any Principal Property which would otherwise be subject to such restrictions, provided that after giving effect thereto, the aggregate amount of all Attributable Debt with
respect to all such Sale and Lease-Back Transactions (not including any Attributable Debt permitted to be incurred pursuant to clauses (1) through (8) of subsection (a) above) plus the aggregate amount of all secured Funded Debt
incurred pursuant to subsection (a) of Section 4.01 (excluding Funded Debt secured by Mortgages permitted by clauses (1) through (8) of the second sentence of subsection (a) thereunder) does not exceed 15 percent of the
Consolidated Net Tangible Assets. 
 ARTICLE 5. 

SUCCESSORS 
 Section 5.01
Merger, Consolidation or Sale of Assets. 
 The Company shall not merge or consolidate with any other Person or Persons (whether or
not affiliated with the Company) or sell, convey, transfer, lease or otherwise dispose of all or substantially all of its property or assets to any other Person or Persons (whether or not affiliated with the Company), unless: 

(i) either: (a) the transaction is a merger or consolidation and the Company is the surviving entity; or (b) the successor Person
(or the Person which acquires by sale, conveyance, transfer or lease all or substantially all of the Company’s property or assets) is a corporation organized under the laws of the United States, any state thereof or the District of Columbia and
expressly assumes, by a supplemental indenture satisfactory to the Trustee, all of the Company’s obligations under the Notes and the Indenture; 

(ii) immediately after giving effect to the transaction and treating the Company’s obligations in connection with or as a result of such
transaction as having been incurred as of the time of such transaction, no Event of Default (and no event or condition which, after notice or lapse of time or both, would become an Event of Default) shall have occurred and be continuing under the
Indenture; and 
 (iii) an Officer’s Certificate is delivered to the Trustee to the effect that both of the conditions set forth in
clauses (i) and (ii) above have been satisfied. 
 In the event of any of the above transactions, if there is a successor Person
as described in clause (i)(b) immediately above, then the successor will expressly assume all of the Company’s obligations under the Indenture and automatically be substituted for the Company in the Indenture and as issuer of the Notes.
Further, if the transaction is in the form of a sale or conveyance, after any such transfer (except in the case of a lease), the Company will be discharged from all obligations and covenants under the Indenture and all Notes issued thereunder. 

  
 20 

 ARTICLE 6. 

DEFAULTS AND REMEDIES 

Section 6.01 Events of Default. 

The Notes shall not have the benefit of the Events of Default set forth in the Base Indenture. Instead, each of the following is an
“Event of Default” with respect to each series of the Notes: 
 (a) the failure to pay interest on any Notes of such series
when the same becomes due and payable and the default continues for a period of 90 days; 
 (b) failure in the payment when due of
principal of or premium, if any, on the Notes of such series; 
 (c) default in the performance or breach of any covenant or warranty of the
Company relating to the Notes of such series, which default continues uncured for a period of 90 days after receipt by the Company of written notice given by the Trustee or Holders of such Notes after the Company and the Trustee receive written
notice from the Holders of not less than a majority in aggregate principal amount of the Notes of such series outstanding; or 
 (d) the
Company or any Material Subsidiary: 
 (i) commences a voluntary case in bankruptcy, 

(ii) consents to the entry of an order for relief against it in an involuntary bankruptcy case, 

(iii) consents to the appointment of a custodian of it or for all or substantially all of its property, 

(iv) makes a general assignment for the benefit of its creditors, or 

(v) generally is unable to pay its debts as they become due; or 

(e) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(i) is for relief against the Company or any Material Subsidiary; 

(ii) appoints a custodian of the Company or any Material Subsidiary for all or substantially all of the property of the
Company or of such Material Subsidiary, as applicable; or 
 (iii) orders the liquidation of the Company or any Material
Subsidiary; 
 and the order or decree remains unstayed and in effect for 90 consecutive days. 

  
 21 

 ARTICLE 7. 

MISCELLANEOUS 
 Section 7.01
Trust Indenture Act Controls. 
 If any provision of this Fourth Supplemental Indenture limits, qualifies or conflicts with the
duties imposed by TIA Section 318(c), the imposed duties will control. 
 Section 7.02 Governing Law. 

THE INTERNAL LAWS OF THE STATE OF NEW YORK WILL GOVERN AND BE USED TO CONSTRUE THIS FOURTH SUPPLEMENTAL INDENTURE AND THE NOTES WITHOUT GIVING
EFFECT TO APPLICABLE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF THE LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED THEREBY. 

Section 7.03 Successors. 

All agreements of the Company in this Fourth Supplemental Indenture and the Notes will bind its successors. All agreements of the Trustee in
this Fourth Supplemental Indenture will bind its successors. 
 Section 7.04 Severability. 

In case any provision in this Fourth Supplemental Indenture or in the Notes will be invalid, illegal or unenforceable, the validity, legality
and enforceability of the remaining provisions will not in any way be affected or impaired thereby. 
 Section 7.05 Counterpart
Originals. 
 The parties may sign any number of copies of this Fourth Supplemental Indenture. Each signed copy will be an original, but
all of them together represent the same agreement. 
 Section 7.06 Table of Contents, Headings, Etc. 

The Table of Contents and Headings of the Articles and Sections of this Fourth Supplemental Indenture have been inserted for convenience of
reference only, are not to be considered a part of this Fourth Supplemental Indenture and will in no way modify or restrict any of the terms or provisions hereof. 

[Signatures on following page] 

  
 22 

 Dated: June 10, 2015 

 

			
	STARBUCKS CORPORATION
		
	By:		/s/ Drew Wolff
	Name: Drew Wolff
	Title: Vice President, Treasurer

  
 Signature Page to
Supplemental Indenture 

 Dated: June 10, 2015 

 

			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee
	
	By: Deutsche Bank National Trust Company
		
	By:		/s/ Irina Golovashchuk
	Name: Irina Golovashchuk
	Title: Vice President
		
	By:		/s/ Jeffrey Schoenfeld
	Name: Jeffrey Schoenfeld
	Title: Vice President

  
 Signature Page to
Supplemental Indenture 

 EXHIBIT A 

(Face of Note) 
 [Insert the Global
Note Legend, if applicable, pursuant to the provisions of the Fourth Supplemental Indenture] 
  

					
					CUSIP: 855244 AG4
			
			2.700% Senior Notes due 2022		
	No. ______				$_____________

 STARBUCKS CORPORATION 

promises to pay to CEDE & CO. or registered assigns, the principal sum of _________ Dollars on June 15, 2022 

Interest Payment Dates: June 15 and December 15 

Record Dates: June 1 and December 1 
 Dated:
June 10, 2015 

  
 A-1 

 
			
	STARBUCKS CORPORATION
		
	By:		 
			Name:
			Title:

 Date: June 10, 2015 

  
 A-2 

 This is one of the Global 

Notes referred to in the 
 within-mentioned Fourth Supplemental
Indenture: 
 Dated: June 10, 2015 
 DEUTSCHE BANK TRUST
COMPANY AMERICAS, as Trustee 
  

			
	By: Deutsche Bank National Trust Company
		
	By:		 
			Name:
			Title:

  
 A-3 

 (Reverse of Note) 

2.700% Senior Notes due 2022 

Capitalized terms used herein have the meanings assigned to them in the Indenture referred to below unless otherwise indicated. 

1. INTEREST. Starbucks Corporation, a Washington corporation (the
“Company”), promises to pay interest on the principal amount of this Note at 2.700% per annum from the date hereof until maturity. The Company will pay interest semiannually on June 15 and December 15 of each
year, or if any such day is not a Business Day, on the next succeeding Business Day (each an “Interest Payment Date”). Interest on the 2022 Notes will accrue from the most recent date to which interest has been paid or, if no
interest has been paid, from the date of issuance; provided that if there is no existing Default in the payment of interest, and if this Note is authenticated between a record date referred to on the face hereof
and the next succeeding Interest Payment Date, interest will accrue from such next succeeding Interest Payment Date; provided, further, that the first Interest Payment Date will
be December 15, 2015. The Company will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal at the rate equal to the then applicable interest rate on the 2022 Notes to the extent
lawful; it will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest at the same rate to the extent lawful. Interest will be computed on the basis of a 360-day year of twelve
30-day months. 
 2. METHOD OF PAYMENT. The Company will pay interest on the 2022 Notes (except defaulted
interest) to the Persons who are registered Holders of 2022 Notes at the close of business on the June 1 or December 1 preceding the Interest Payment Date, even if such 2022 Notes are canceled after such record date and on or before such
Interest Payment Date, except as provided in Section 2.13 of the Base Indenture with respect to defaulted interest. Principal, premium, if any, and interest on the 2022 Notes will be payable at the office or agency of the Paying Agent
and Registrar within the Borough of Manhattan in the City of New York or, at the option of the Company, payment of interest may be made by check mailed to the Holders of the 2022 Notes at their respective addresses set forth in the register of
Holders of 2022 Notes; provided that all payments of principal, premium and interest with respect to 2022 Notes the Holders of which have given wire transfer instructions to the Trustee will be required to be made by wire transfer of
immediately available funds to the accounts specified by the Holders thereof. Such payment will be in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts.

 3. PAYING AGENT AND REGISTRAR. Initially, Deutsche Bank Trust Company Americas, the Trustee under the Indenture, will
act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. 

4. INDENTURE. This Note is one of a duly authenticated series of securities of the Company
issued and to be issued in one or more series under an indenture (the “Base Indenture”), dated as of August 23, 2007 between the Company and the Trustee, as amended by the Fourth Supplemental Indenture (the
“Fourth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), dated as of June 10, 2015, between the Company and the 

  
 A-4 

 
Trustee. The terms of the 2022 Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (15 U.S. Code Sections.77aaa-77bbbb). The 2022 Notes are subject to all such terms, and Holders are referred to the Indenture and such Act for a statement of such terms. To the extent any provision of this Note conflicts
with the express provisions of the Base Indenture, the provisions of the Note will govern and be controlling, and to the extent any provision of the Note conflicts with the Fourth Supplemental Indenture, the provisions of the Fourth Supplemental
Indenture will govern and be controlling, and to the extent any provision of the Base Indenture conflicts with the express provisions of the Fourth Supplemental Indenture, the provisions of the Fourth Supplemental Indenture will govern and be
controlling. The Company will be entitled to issue Additional Notes pursuant to Section 2.03 of the Fourth Supplemental Indenture. 

5. OPTIONAL REDEMPTION. 

At any time prior to April 15, 2022 (two months prior to the maturity date of the 2022 Notes), the 2022 Notes will be redeemable, in
whole at any time or in part from time to time, at the Company’s option, at a redemption price equal to the greater of: 

(i) 100% of the aggregate principal amount of the 2022 Notes to be redeemed; or 

(ii) the sum of the present values of the remaining scheduled payments of principal and interest on the 2022 Notes being
redeemed (not including any portion of any payments of interest accrued to the redemption date) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus
12 basis points, 
 plus, in each case, accrued and unpaid interest on the 2022 Notes being redeemed to the redemption date. 

Calculation of the foregoing shall be made by the Company or on the Company’s behalf by such Person as the Company shall designate;
provided, however, that such calculation shall not be a duty or obligation of the Trustee. 
 At any time on and after
April 15, 2022 (two months prior to the maturity date of the 2022 Notes), the Issuer may redeem some or all of the 2022 Notes, at a redemption price equal to 100% of the principal amount of the 2022 Notes to be redeemed plus accrued and unpaid
interest on the principal amount being redeemed to the date of redemption. 
 On and after the redemption date, interest will cease to
accrue on the 2022 Notes or portions thereof called for redemption as long as the Company has deposited with the Paying Agent funds in satisfaction of the applicable redemption price. 

6. MANDATORY REDEMPTION. Except as set forth in paragraph 7, the Company shall not be required to make mandatory redemption payments
with respect to the 2022 Notes. 
 7. REPURCHASE AT OPTION OF HOLDER. 

  
 A-5 

 Upon the occurrence of a Change of Control Triggering Event, the Company will be required to
offer to purchase all of the outstanding 2022 Notes at a purchase price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the date of purchase. 

8. NOTICE OF REDEMPTION. Notice of redemption will be mailed at least 30 days but not more than 60 days before the redemption
date to each Holder whose 2022 Notes are to be redeemed at its registered address. No 2022 Notes of a principal amount of $2,000 or less shall be redeemed in part. 

9. DENOMINATIONS, TRANSFER, EXCHANGE. The 2022 Notes are in registered form without coupons in denominations of $2,000 and
integral multiples of $1,000. The 2022 Notes may be transferred or exchanged as provided in the Fourth Supplemental Indenture. The Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements
and transfer documents and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Fourth Supplemental Indenture. The Company need not exchange or transfer any Note or portion of a Note selected for
redemption, except for the unredeemed portion of any Note being redeemed in part. Also, the Company need not exchange or register the transfer of any 2022 Notes for a period of 15 days before a selection of 2022 Notes to be redeemed or during
the period between a record date and the corresponding Interest Payment Date. 
 10. PERSONS DEEMED OWNERS. The registered
Holder of a Note may be treated as its owner for all purposes. 
 11. AMENDMENT, SUPPLEMENT AND WAIVER. The Base Indenture may be
amended as provided therein. Subject to certain exceptions, the Fourth Supplemental Indenture or the 2022 Notes may be amended or supplemented with the consent of the Holders of at least a majority in principal amount of the 2022 Notes then
outstanding, including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, 2022 Notes, voting as a single class, and compliance with any provision of the Indenture or the 2022 Notes may be
waived with the consent of the Holders of a majority in principal amount of the then outstanding 2022 Notes, including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, 2022 Notes, voting
as a single class. Without the consent of any Holder of a Note, the Fourth Supplemental Indenture or the 2022 Notes may be amended or supplemented (i) to cure any ambiguity, defect or inconsistency; (ii) to provide for uncertificated Notes
in addition to or in place of certificated Notes; (iii) to provide for the assumption of the Company’s obligations to Holders of the 2022 Notes in case of a merger or consolidation or sale of all or substantially all of the Company’s
assets; (iv) to make any change that would provide any additional rights or benefits to the Holders of the 2022 Notes or that does not adversely affect the legal rights under the Fourth Supplemental Indenture of any such Holder; (v) to
comply with the requirements of the SEC in order to effect or maintain the qualification of the Indenture under the Trust Indenture Act; (vi) to provide for the issuance of Additional Notes in accordance with the Fourth Supplemental Indenture;
or (vii).to evidence and provide for the acceptance of appointment by a successor: trustee with respect to the Notes. 

12. DEFAULTS AND REMEDIES. An “EVENT OF DEFAULT” occurs if: (i) default for a period of 90 days in the payment
when due of interest on the 2022 Notes; (ii)  

  
 A-6 

 
default in the payment when due of principal of or premium, if any, on the 2022 Notes; (iii) the Company fails for 90 days after receipt of notice to the Company to comply with any
covenant or warranty of the Company in the Indenture; or (iv) certain events of bankruptcy or insolvency occur with respect to the Company or any Material Subsidiary. 

If any Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the then outstanding 2022
Notes may declare all the 2022 Notes to be due and payable. Notwithstanding the foregoing, in the case of an Event of Default arising from certain events of bankruptcy or insolvency with respect to the Company or any Material Subsidiary, all
outstanding 2022 Notes will become due and payable without further action or notice. Holders may not enforce the Indenture or the 2022 Notes except as provided in the Indenture. Subject to certain limitations, Holders of a majority in principal
amount of the then outstanding 2022 Notes may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of the 2022 Notes notice of any continuing Default or Event of Default if it determines that withholding
notice is in their interest, except a Default or Event of Default relating to the payment of principal, premium or interest. The Holders of a majority in aggregate principal amount of the 2022 Notes then outstanding by notice to the Trustee may on
behalf of the Holders of all of the 2022 Notes waive any existing Default or Event of Default and its consequences under the Indenture except a continuing Default or Event of Default in the payment of interest on, or the principal of, the 2022
Notes. The Company is required to deliver to the Trustee annually a statement regarding compliance with the Indenture, and the Company is required no later than five days after becoming aware of any Default or Event of Default to deliver to the
Trustee a statement specifying such Default or Event of Default. 
 13. TRUSTEE DEALINGS WITH COMPANY. The Trustee, in its
individual or any other capacity, may make loans to, accept deposits from, and perform services for the Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were not the Trustee. 

14. NO RECOURSE AGAINST OTHERS. A director, officer, employee, incorporator or stockholder, of the Company, as such, will not
have any liability for any obligations of the Company under the 2022 Notes or the Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of 2022 Notes by accepting a Note waives
and releases all such liability. The waiver and release are part of the consideration for the issuance of the 2022 Notes. 

15. AUTHENTICATION. This Note will not be valid until authenticated by the manual signature of the Trustee or an authenticating
agent. 
 16. ABBREVIATIONS. Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN
COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

17. CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the
Company has caused CUSIP numbers to be printed on the 2022 Notes and the Trustee may use CUSIP numbers in notices of  

  
 A-7 

 
redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the 2022 Notes or as contained in any notice of redemption and
reliance may be placed only on the other identification numbers placed thereon. The Company will furnish to any Holder upon written request and without charge a copy of the Base Indenture and the Fourth Supplemental Indenture. Requests
may be made to: 
 Starbucks Corporation 

2401 Utah Avenue South 
 Seattle,
Washington 98134 
 Facsimile No.: (206) 318-1045 

Attention: General Counsel 

  
 A-8 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
  

			
	(I) or (we) assign and transfer this Note to:		 
			(Insert assignee’s legal name)

  
  

(Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably appoint _____________________________________________ to transfer this Note on the books of the Company: The agent
may substitute another to act for him. 
 Date: _________________ 

 

			
		
	Your Signature:		 
			 (sign exactly as your name appears

on the face of this senior note)

 
			
		
	Tax Identification No.:		 

 
			
		
	Signature Guarantee:		 

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in
addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 A-9 

 Option of Holder to Elect Purchase 

If you want to elect to have this Note purchased by the Company pursuant to Section 4.02 of the Fourth Supplemental Indenture, check the
box below: 
  

	 	 ̈	Section 4.02 

 If you want to elect to have only part of the Note purchased by the Company
pursuant to Section 4.02 of the Fourth Supplemental Indenture, state the amount you elect to have purchased: 
 $ 

Date: _______________________________________ 
  

			
		
	Your Signature:		 
			 (sign exactly as your name appears
 on the
face of this senior note)

 
			
		
	Tax Identification No.:		 

 
			
		
	Signature Guarantee:		 

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other
“signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 A-10 

 EXHIBIT B 

(Face of Note) 
 [Insert the Global
Note Legend, if applicable, pursuant to the provisions of the Fourth Supplemental Indenture] 
  

					
					CUSIP: 855244 AH2
			4.300% Senior Notes due 2045		
	No. ______				$_____________
			
			STARBUCKS CORPORATION		

 promises to pay to CEDE & CO. or registered assigns, the principal sum of _________ Dollars on June 15, 2045 

Interest Payment Dates: June 15 and December 15 
 Record
Dates: June 1 and December 1 
 Dated: June 10, 2015 

  
 B-1 

 
			
	STARBUCKS CORPORATION
		
	By:		 
			Name:
			Title:

 Date: June 10, 2015 

  
 B-2 

 This is one of the Global 

Notes referred to in the 
 within-mentioned Fourth Supplemental
Indenture: 
 Dated: June 10, 2015 
 DEUTSCHE BANK TRUST
COMPANY AMERICAS, as Trustee 
  

			
	By: Deutsche Bank National Trust Company
		
	By:		 
			Name:
			Title:

  
 B-3 

 (Reverse of Note) 

4.300% Senior Notes due 2045 

Capitalized terms used herein have the meanings assigned to them in the Indenture referred to below unless otherwise indicated. 

1. INTEREST. Starbucks Corporation, a Washington corporation (the
“Company”), promises to pay interest on the principal amount of this Note at 4.300% per annum from the date hereof until maturity. The Company will pay interest semiannually on June 15 and December 15 of each
year, or if any such day is not a Business Day, on the next succeeding Business Day (each an “Interest Payment Date”). Interest on the 2045 Notes will accrue from the most recent date to which interest has been paid or, if no
interest has been paid, from the date of issuance; provided that if there is no existing Default in the payment of interest, and if this Note is authenticated between a record date referred to on the face hereof
and the next succeeding Interest Payment Date, interest will accrue from such next succeeding Interest Payment Date; provided, further, that the first Interest Payment Date will
be December 15, 2015. The Company will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal at the rate equal to the then applicable interest rate on the 2045 Notes to the extent
lawful; it will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest at the same rate to the extent lawful. Interest will be computed on the basis of a 360-day year of twelve
30-day months. 
 2. METHOD OF PAYMENT. The Company will pay interest on the 2045 Notes (except defaulted
interest) to the Persons who are registered Holders of 2045 Notes at the close of business on the June 1 or December 1 preceding the Interest Payment Date, even if such 2045 Notes are canceled after such record date and on or before such
Interest Payment Date, except as provided in Section 2.13 of the Base Indenture with respect to defaulted interest. Principal, premium, if any, and interest on the 2045 Notes will be payable at the office or agency of the Paying Agent
and Registrar within the Borough of Manhattan in the City of New York or, at the option of the Company, payment of interest may be made by check mailed to the Holders of the 2045 Notes at their respective addresses set forth in the register of
Holders of 2045 Notes; provided that all payments of principal, premium and interest with respect to 2045 Notes the Holders of which have given wire transfer instructions to the Trustee will be required to be made by wire transfer of
immediately available funds to the accounts specified by the Holders thereof. Such payment will be in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts.

 3. PAYING AGENT AND REGISTRAR. Initially, Deutsche Bank Trust Company Americas, the Trustee under the Indenture, will
act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to any Holder. The Company or any of its Subsidiaries may act in any such capacity. 

4. INDENTURE. This Note is one of a duly authenticated series of securities of the Company
issued and to be issued in one or more series under an indenture (the “Base Indenture”), dated as of August 23, 2007 between the Company and the Trustee, as amended by the Fourth Supplemental Indenture (the
“Fourth Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), dated as of June 10, 2015, between the Company and the 

  
 B-4 

 
Trustee. The terms of the 2045 Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (15 U.S. Code Sections.77aaa-77bbbb). The 2045 Notes are subject to all such terms, and Holders are referred to the Indenture and such Act for a statement of such terms. To the extent any provision of this Note conflicts
with the express provisions of the Base Indenture, the provisions of the Note will govern and be controlling, and to the extent any provision of the Note conflicts with the Fourth Supplemental Indenture, the provisions of the Fourth Supplemental
Indenture will govern and be controlling, and to the extent any provision of the Base Indenture conflicts with the express provisions of the Fourth Supplemental Indenture, the provisions of the Fourth Supplemental Indenture will govern and be
controlling. The Company will be entitled to issue Additional Notes pursuant to Section 2.03 of the Fourth Supplemental Indenture. 

5. OPTIONAL REDEMPTION. 

At any time prior to December 15, 2044 (six months prior to the maturity date of the 2045 Notes), the 2045 Notes will be redeemable, in
whole at any time or in part from time to time, at the Company’s option, at a redemption price equal to the greater of: 

(i) 100% of the aggregate principal amount of the 2045 Notes to be redeemed; or 

(ii) the sum of the present values of the remaining scheduled payments of principal and interest on the 2045 Notes being
redeemed (not including any portion of any payments of interest accrued to the redemption date) discounted to the redemption date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 20 basis
points, 
 plus, in each case, accrued and unpaid interest on the 2045 Notes being redeemed to the redemption date. 

Calculation of the foregoing shall be made by the Company or on the Company’s behalf by such Person as the Company shall
designate; provided, however, that such calculation shall not be a duty or obligation of the Trustee. 
 At any time on
and after December 15, 2044 (six months prior to the maturity date of the 2045 Notes), the 2045 Notes will be redeemable in whole at any time or in part from time to time, at the Company’s option, at a redemption price equal to 100% of the
principal amount of the 2045 Notes to be redeemed plus accrued and unpaid interest on the principal amount being redeemed to the date of redemption. 

On and after the redemption date, interest will cease to accrue on the 2045 Notes or portions thereof called for redemption as long as the
Company has deposited with the Paying Agent funds in satisfaction of the applicable redemption price. 
 6. MANDATORY REDEMPTION.
Except as set forth in paragraph 7, the Company shall not be required to make mandatory redemption payments with respect to the 2045 Notes. 

  
 B-5 

 7. REPURCHASE AT OPTION OF HOLDER. 

Upon the occurrence of a Change of Control Triggering Event, the Company will be required to offer to purchase all of the outstanding 2045
Notes at a purchase price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the date of purchase. 

8. NOTICE OF REDEMPTION. Notice of redemption will be mailed at least 30 days but not more than 60 days before the redemption
date to each Holder whose 2045 Notes are to be redeemed at its registered address. No 2045 Notes of a principal amount of $2,000 or less shall be redeemed in part. 

9. DENOMINATIONS, TRANSFER, EXCHANGE. The 2045 Notes are in registered form without coupons in denominations of $2,000 and integral
multiples of $1,000. The 2045 Notes may be transferred or exchanged as provided in the Fourth Supplemental Indenture. The Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer documents
and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Fourth Supplemental Indenture. The Company need not exchange or transfer any Note or portion of a Note selected for redemption, except for the
unredeemed portion of any Note being redeemed in part. Also, the Company need not exchange or register the transfer of any 2045 Notes for a period of 15 days before a selection of 2045 Notes to be redeemed or during the period between a record date
and the corresponding Interest Payment Date. 
 10. PERSONS DEEMED OWNERS. The registered Holder of a Note may be treated as its
owner for all purposes. 
 11. AMENDMENT, SUPPLEMENT AND WAIVER. The Base Indenture may be amended as provided therein. Subject to
certain exceptions, the Fourth Supplemental Indenture or the 2045 Notes may be amended or supplemented with the consent of the Holders of at least a majority in principal amount of the 2045 Notes then outstanding, including, without limitation,
consents obtained in connection with a purchase of, or tender offer or exchange offer for, 2045 Notes, voting as a single class, and compliance with any provision of the Indenture or the 2045 Notes may be waived with the consent of the Holders of a
majority in principal amount of the then outstanding 2045 Notes, including, without limitation, consents obtained in connection with a purchase of, or tender offer or exchange offer for, 2045 Notes, voting as a single class. Without the consent of
any Holder of a Note, the Fourth Supplemental Indenture or the 2045 Notes may be amended or supplemented (i) to cure any ambiguity, defect or inconsistency; (ii) to provide for uncertificated Notes in addition to or in place of
certificated Notes; (iii) to provide for the assumption of the Company’s obligations to Holders of the 2045 Notes in case of a merger or consolidation or sale of all or substantially all of the Company’s assets; (iv) to make any
change that would provide any additional rights or benefits to the Holders of the 2045 Notes or that does not adversely affect the legal rights under the Fourth Supplemental Indenture of any such Holder; (v) to comply with the requirements of
the SEC in order to effect or maintain the qualification of the Indenture under the Trust Indenture Act; (vi) to provide for the issuance of Additional Notes in accordance with the Fourth Supplemental Indenture; or (vii).to evidence and provide for the acceptance of appointment by a successor: trustee with respect to the Notes. 

  
 B-6 

 12. DEFAULTS AND REMEDIES. An “EVENT OF DEFAULT” occurs if:
(i) default for a period of 90 days in the payment when due of interest on the 2045 Notes; (ii) default in the payment when due of principal of or premium, if any, on the 2045 Notes; (iii) the Company fails for 90 days after
receipt of notice to the Company to comply with any covenant or warranty of the Company in the Indenture; or (iv) certain events of bankruptcy or insolvency occur with respect to the Company or any Material Subsidiary. 

If any Event of Default occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of the then outstanding 2045
Notes may declare all the 2045 Notes to be due and payable. Notwithstanding the foregoing, in the case of an Event of Default arising from certain events of bankruptcy or insolvency with respect to the Company or any Material Subsidiary, all
outstanding 2045 Notes will become due and payable without further action or notice. Holders may not enforce the Indenture or the 2045 Notes except as provided in the Indenture. Subject to certain limitations, Holders of a majority in principal
amount of the then outstanding 2045 Notes may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Holders of the 2045 Notes notice of any continuing Default or Event of Default if it determines that withholding
notice is in their interest, except a Default or Event of Default relating to the payment of principal, premium or interest. The Holders of a majority in aggregate principal amount of the 2045 Notes then outstanding by notice to the Trustee may on
behalf of the Holders of all of the 2045 Notes waive any existing Default or Event of Default and its consequences under the Indenture except a continuing Default or Event of Default in the payment of interest on, or the principal of, the 2045
Notes. The Company is required to deliver to the Trustee annually a statement regarding compliance with the Indenture, and the Company is required no later than five days after becoming aware of any Default or Event of Default to deliver to the
Trustee a statement specifying such Default or Event of Default. 
 13. TRUSTEE DEALINGS WITH COMPANY. The Trustee, in its
individual or any other capacity, may make loans to, accept deposits from, and perform services for the Company or its Affiliates, and may otherwise deal with the Company or its Affiliates, as if it were not the Trustee. 

14. NO RECOURSE AGAINST OTHERS. A director, officer, employee, incorporator or stockholder, of the Company, as such, will not
have any liability for any obligations of the Company under the 2045 Notes or the Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of 2045 Notes by accepting a Note waives
and releases all such liability. The waiver and release are part of the consideration for the issuance of the 2045 Notes. 

15. AUTHENTICATION. This Note will not be valid until authenticated by the manual signature of the Trustee or an authenticating
agent. 
 16. ABBREVIATIONS. Customary abbreviations may be used in the name of a Holder or an assignee, such as: TEN
COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (= Uniform Gifts to Minors Act). 

  
 B-7 

 17. CUSIP NUMBERS. Pursuant to a recommendation promulgated by the Committee on
Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the 2045 Notes and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the
accuracy of such numbers either as printed on the 2045 Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. The Company will furnish to any Holder upon written
request and without charge a copy of the Base Indenture and the Fourth Supplemental Indenture. Requests may be made to: 

Starbucks Corporation 
 2401 Utah
Avenue South 
 Seattle, Washington 98134 

Facsimile No.: (206) 318-1045 

Attention: General Counsel 

  
 B-8 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: 
  

			
	(I) or (we) assign and transfer this Note to:		 
			(Insert assignee’s legal name)

  
  

(Insert assignee’s soc. sec. or tax I.D. no.) 
  

 
  

 
  

 
  

 
 (Print or type assignee’s name,
address and zip code) 
 and irrevocably appoint ____________________________________ to transfer this Note on the books of the Company: The agent may
substitute another to act for him. 
 Date: ___________________________ 

 

			
		
	Your Signature:		 
			 (sign exactly as your name appears
 on the face
of this senior note)

 
			
		
	Tax Identification No.:		 

 
			
		
	Signature Guarantee:		 

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in
addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 B-9 

 Option of Holder to Elect Purchase 

If you want to elect to have this Note purchased by the Company pursuant to Section 4.02 of the Fourth Supplemental Indenture, check the
box below: 
  

	 	 ̈	Section 4.02 

 If you want to elect to have only part of the Note purchased by the Company
pursuant to Section 4.02 of the Fourth Supplemental Indenture, state the amount you elect to have purchased: 
 $ 

Date: _______________________ 
  

			
		
	Your Signature:		 
			 (sign exactly as your name appears
 on the
face of this senior note)

 
			
		
	Tax Identification No.:		 

 
			
		
	Signature Guarantee:		 

 Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of
the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other
“signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 B-10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00246-of-00352.parquet"}]]